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Abstract
This thesis comprised a series of population-based studies, based on two separate  
cohorts of healthy preterm and term infants, undertaken to examine factors 
determining respiratory function during infancy, together with the developm ent of sex- 
specific reference data  for maximal expiratory flow at functional residual capacity  
( V ’maxFRc).
108 preterm infants without respiratory disease were recruited to investigate whether, 
after adjustment for body size, respiratory function in the neonatal period is reduced in 
those exposed to maternal smoking prenatally. At -36 weeks post-menstrual age, and  
prior to any postnatal smoke exposure, breathing patterns were altered and V'maxFRc 
reduced in those whose mothers smoked antenatally, in white com pared with black 
infants and in boys compared with girls. Repeat measures of V ’maxFRc in a subset of this 
preterm cohort (n=24) showed that, despite similar size-corrected values shortly after 
birth, a t 1 year corrected postnatal ag e  V'maxFRc was significantly lower (-2 Z score) 
than in term infants, with marked ‘tracking’ of lung function between test occasions, 
suggesting that preterm delivery per se may adversely affect subsequent airway 
development.
Using the raised volume technique, airway function was assessed in 234 term infants (98 
with low birth weight for gestational ag e  [SGA]). At -6  weeks postnatal age, after 
adjusting for relevant covariates including body size, airway function was significantly 
lower among SGA infants, in boys com pared with girls and in those exposed to 
maternal smoking antenatally. Follow-up measurements at -8-9 months in 80 infants (32 
SGA) of non-smoking mothers demonstrated considerable ‘tracking’ of airway 
function, with forced expired volume in 0.4 s (FEV04) being -9% lower in SGA infants 
throughout the first year (95% Cl: 2% to 16%). These results suggest that adverse 
prenatal events may constrain lung development with potential long-term effects of 
respiratory health. In summary, maternal smoking during pregnancy, sex, preterm  
delivery and being born SGA may exert independent effects on airway function during 
infancy.
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challenge agent causing n% fall in forced flow
P M A post-menstrual age (= sum of GA and PNA) weeks
P def deflation pressure kPa; cmhhO
PEFV partial forced expiratory flow-volume (curve)
PEF peak expiratory flow mL-s'1
Pei elastic recoil pressure kPa; cmhhO
P inf airway inflation pressure KPa; cmhhO
Pi jacket pressure kPa
pleth plethysmographic
Ppi pleural pressure kPa; cmPhO
PNA postnatal age weeks; months
PNT pneumotachometer
P, (jacket) transmission pressure kPa; cmhhO
P.p transpulmonary pressure kPa; cmhhO
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Abbreviations/
Symbols Description Unit
P-V Pressure-volume (curve)
r2 coefficient of determination
RASP Respiratory Analysis Program
Raw resistance of the airways kPa-l/'-s
RDS respiratory distress syndrome
ref reference
R E M rapid eye movement
RFT respiratory function test
RIP respiratory inductive plethysmograph
RR respiratory rate m im 1
Rrs resistance of the respiratory system kPa-L'-s
RSD residual standard deviation
RSV respiratory syncytial virus
RTC rapid thoraco-abdominal compression
RV residual volume mL
RVRTC raised volume RTC (technique)
s Second
SBT single (breath) occlusion technique
SD standard deviation
SDS standard deviation (or Z) score
SGA small for gestational age
Sp02 pulsatile oxygen saturation %
SGaw specific airway conductance s_,-kPa
SRaw specific airway resistance kPa-s~'
I tau; time constant s
t time s
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Abbreviations/
Symbols Description Unit
TC threshold concentration ot an inhalational 
challenge agent causing a x% fall in forced flow
tE expiratory time s
t  F E duration of forced expiration s
TGV thoracic gas volume mL
t, inspiratory time s
TLC total lung capacity mL
tpTEF time to peak tidal expiratory flow s
URTI upper respiratory tract illness
V Volume mL
V int Inflation volume mL
V ’ flow mL-s"1
V maxFRC maximal expiratory flow at functional residual 
capacity
mL-s"1
Vi tidal volume mL
w week
y year
Z score SD score
Conversion factors
Pressure 1 cmHbO = 0.098 kPa
Pressure 1 mmHg = 0.133 kPa
Resistance 1 cmhhOL'-s = 0.098 kPa-L'-s
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Glossary of terms used in this thesis
Term Definition
Airway conductance Reciprocal of airway resistance (L-s 1 -kPa-1)
Appropriate tor gestational Infant whose birth weight lies between the 20th and 95,h
age (AGA) infant centile for gestational age
Coefficient of variation (CV) (Standard deviation/mean) x 100
Com pliance (C) A measure of distensibility, i.e., change in volume per unit 
change in pressure:
C = volume/pressure (mL-kPa1)
Elastance (E) A measure of lung resistance to distension, i.e. a reciprocal 
of compliance:
E= 1 /C  (kPa-mL1)
Heteroscedasticity This is caused by non-normality of one of the variables, an 
indirect relationship between variables, or to the effect of a 
data  transformation. Heteroscedasticity can be dealt with 
either by undertaking separate analyses for subgroups of 
subjects with similar typical errors (e.g., males and females), 
or by transforming the variable.
Homoscedasticity The assumption that the variability in scores for one variable 
is roughly the same at all values of the other variable, which 
is related to normality. Homoscedasticity is detected  with 
scatterplots and is rectified through transformation.
Jacket pressure transmission Percent change in pressure at the airway opening 
(Pao)/jacket pressure (Pj) during a brief airway occlusion
Odds The chance or balance of probability in favour of, or 
against, some outcome
i.e., (the number of individuals with the outcom e)/(num ber 
of individuals without the outcome)
Odds ratio (OR) The ratio of the odds of having the target outcome (e.g., 
asthma [a]) in the index group (e.g., smokers [b]) relative to 
the odds in favour of, or against, having the target outcome  
[c] in the control group (e.g., non-smokers [d])
OR = (a /[b -a ))*(c /(d -c ])
p-value A measure of the strength of evidence against the null 
hypothesis
phenotype the physical and biochemical characteristics of an organism 
(or specific individual) as determined by the interaction of its 
genetic constitution and the environment
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Term Definition
Relative risk (RR)
Resistance (R)
Specific airway 
conductance
Type I random error 
Type II random error
RR is a ratio of risk probabilities, i.e.,
= no. of individual with outcome (e.g., asthma) [a]/total no. 
of individuals in this group (e.g., smokers) [a+b]/no. of 
individuals with the outcome (c)/no. of cases in a 2nd group 
(e.g., non-smokers) [c+d];
i.e., RR between groups = (a /[a+b])/(c /[c+d])
A measure of pressure required to move gas/gases at a flow 
of one litre per second:
R = pressure/flow (kPa-L Ks)
Airway conductance/Functional residual capacity (s-'-kPa-1)
Falsely concluding that the null hypothesis is false when in 
fact it is true. The p-value gives a measure of how likely this is 
to have occurred
Falsely concluding that the null hypothesis is true when in 
fact it is false. This fype of error commonly occurs when fhe 
study is under-powered due to insufficient sample size
21
Peer reviewed publications associated with the studies presented in this 
thesis
a) Original papers
Stocks J, H enschen M, Hoo AF, C oste loe  K, D ezateu x C. [1997]
In fluence  of ethnicity a n d  g e n d e r on a irw ay  function in preterm  infants. Am J Respir Crit 
C a re  M ed ; 156; 1855-1862.
Hoo AF, Henschen M, D ezateux C, C oste loe K, Stocks J. [1998]
Respiratory function am o n g  preterm  infants whose mothers sm oked during p re g n an cy . 
Am  J Respir Crit C a re  M ed; 158:700-705.
Lum S, Hoo AF, Dezateux C, G o etz  I, W a d e  A, DeRooy L, C oste loe K, Stocks J. [2001 ]
The association b e tw e e n  birthweight, sex, a n d  a irw ay function in infants of nonsm oking  
mothers. Am J Respir Crit C a re  M ed ; 164:2078-2084
Hoo AF, D ezateux C, H anrahan  JP, C o le  TJ, Tepper RS, Stocks J. [2002]
Sex-specific pred iction  equations for V'maxFRc in infancy: a  m ulticenter co lla b o ra tive  
study. Am J Respir Crit C a re  M ed; 165:1084-1092.
Hoo AF, D ezateu x  C, Henschen M, C oste loe  K, Stocks J. [2002]
D eve lo p m en t of a irw ay function in in fancy a fte r preterm  delivery. J Pediatr;l 4 1 :652-658.
Dezateux C, Lum S, Hoo AF, H aw d o n  J, C oste loe  K, Stocks J. [2004
Low birth w eigh t for gestation a n d  a irw ay  function in infancy: exploring the  fe ta l origins 
hypothesis. Thorax;59:60-66.
Hoo AF, Stocks J, Lum S, W a d e  AM, C astle  RA, C osteloe KL, D ezateu x  C. [2004]
D eve lo p m en t of lung function in early life: in fluence of birth w e ig h t in infants of 
nonsmokers. Am J Respir Crit C a re  M ed ; 170:527-533.
22
b) Methodological papers
Henschen M, Stocks J, Hoo AF, Dixon P. [1998]
Analysis of fo rc e d  expiratory m anoeuvers  from raised lung volum es in preterm  infants.
J A ppl Physiol;85:1989-1997.
Hoo AF, Lum SY, G o e tz  I, D ezateu x C, Stocks J. [2001 ]
In flu en ce  of ja c k e t p la c e m e n t on respiratory c o m p lia n c e  during raised lung vo lum e  
m easurem ents  in infants. Pediatr Pulmonol;31:51-58.
R a n g a n a th a n  SC, Hoo AF, Lum SY, G o e tz  I, C astle  RA, Stocks J. [2002]
Exploring the relationship b e tw e e n  fo rced  m axim al flow a t functional residual c a p a c ity  
a n d  param eters  of fo rced  expiration from raised lung vo lum e in healthy  infants. Pediatr 
Pulm onol;33:419-428.
Lum S, Hoo AF, Stocks J. [2002]
Effect of a irw ay inflation pressure on fo rc e d  expiratory m aneuvers from raised lung  
volum e in infants. Pediatr Pulm onol;33:130-134.
Lum S, Hoo AF, Stocks J. [2002]
In fluence of ja c k e t tightness a n d  pressure on raised lung vo lum e fo rced  expiratory  
m aneuvers in infants. Pediatr Pulm onol;34:361-368.
Lum S, Hulskamp G, Hoo AF, Ljungberg H, Stocks J. [2004]
Effect of the  raised lung vo lum e tec h n iq u e  on subsequent measures of V'maxFRc in infants. 
Pediatr Pulm onol;38:146-154.
Note: All publications are available as PDFs in the CD at the back of this thesis.
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1. Introduction and literature review
1.1. OVERVIEW
Respiratory diseases are a major cause of morbidity and mortality during childhood, 
particularly during the first year of life. Wheezing in young children is extremely common in 
the industrialised world, particularly during viral infections. Assessment of respiratory 
function is an integral part of the diagnostic and clinical m anagem ent of older children 
and adults with respiratory disease, but such tests are more difficult to apply during infancy 
and early childhood, as will be discussed below.
Assessment of respiratory function in infants and young children has significantly 
contributed to our understanding of respiratory physiology and normal development, not 
just during childhood but throughout life. This is particularly relevant since evidence from 
several epidemiological studies using respiratory function measurements have linked sub- 
optimal respiratory function shortly after birth with subsequent development of respiratory 
disorders [ l -6]. Thus, knowledge of developmental physiology and growth of the 
respiratory system at birth and early infancy is an important component of the clinical 
interpretation, diagnosis and m anagem ent of disease in infants and young children. To 
improve future treatment for airway diseases such as asthma, cystic fibrosis (CF) and  
chronic lung disease of infancy (CLDI), and to minimise the associated rate of morbidity 
and mortality, it is crucial that the body of knowledge regarding the physiological and  
pathological processes involved in these diseases is strengthened. Furthermore, an 
understanding of developmental anatom y and physiology is essential for clinical 
measurement and interpretation of respiratory function tests (RFTs) in infants and young 
children.
In the following sections, the burden of respiratory disease, the growth and developm ent 
of the respiratory system and factors influencing respiratory function during infancy are 
outlined. The role and history of respiratory function measurements are briefly reviewed, 
leading to the development of tests for use in infancy. The differences in respiratory 
physiology between infants and older subjects are described. The application of RFTs in 
infancy and the theory of the most commonly used techniques to assess airway function 
(namely, those based on forced expiratory manoeuvres) are discussed in this chapter, 
together with a summary of published literature on studies using such techniques. This 
chapter concludes by summarising the aims and objectives of this thesis.
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1.2. THE BURDEN OF RESPIRATORY DISEASE
In Europe, as well as the rest ot the world, lung diseases are among the leading causes ot 
mortality and morbidity. Recent publications reported the disturbing tact that currently in 
the UK, respiratory diseases have superseded cardiovascular disorders in becoming the 
leading killer [7:8]. The UK death rates due to respiratory diseases are among the highest in 
Europe, being nearly twice the European Union (EU) average. In 2000, respiratory disease 
cost the National Health Service (NHS) £2,576 million, more than any other disease area
[7].
In Western, Central and Eastern Europe, pneumonia, chronic obstructive pulmonary 
disease (COPD) and lung cancer are the main respiratory causes ot death in adults [8]. It is 
estimated that in 2020, of the 68.3 million deaths worldwide, 11.9 million will be caused by 
lung disease, with COPD becoming the major respiratory cause of death (Table 1.1). 
Globally, paediatric respiratory disease is a major cause of morbidity in children 
accounting for a large proportion of childhood hospitalisations, healthcare consultations 
and absenteeism from day care centres or schools [9-l l ] .  In developed countries, 
although the number of deaths from respiratory illness is relatively low (-8% of all childhood 
deaths in England and Wales), nevertheless the burden is high particularly in children 
under five years of age, due to bronchiolitis, wheezing illnesses and CLDI [7;12]. The 
detrimental effects of smoking on lung health are well recognised [8; 13]. However, lung 
problems are not just smoking-related; there is a wide variety of other causes ranging from 
genetic influences to nutritional, environmental and poverty-related factors. Since the 
associations between respiratory health status and these factors are potentially complex, 
different respiratory diseases require different approaches and treatments. During the last 
decade, there has been increasing recognition that altered lung growth and  
development in utero  due to sub-optimal intrauterine conditions and/or lung injury 
associated with inflammation and infections during the first years of life may have  
important implications for long-term lung health [14-16]. Since lung growth and  
development occur most rapidly during the first few years of life, improvement of the 
knowledge base regarding early growth and development of the respiratory system is 
essential to the understanding of the effects of lung disease and how to prevent and  
minimise subsequent lung dam age.
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Table 1.1. Leading causes of death worldwide in 1990 and the prediction for 2020
Causes of death 1990 t 2020 1
Lung disease (all causes) 9.4 (18.7) 11.9 (17.4)
P neum on ia 4.3 (8.5) 2.5 (3.6)
COPD 2.2 (4.3) 4.7 (6.8)
Tuberculosis 2.0 (3.9) 2.4 (3.5)
Lung c a n c e r 0.95 (1.8) 2.3 (3.3)
Ischaemic heart disease 6.3 (12.4) 11.1 (16.2)
Cerebrovascular disease 4.4 (8.7) 7.7 (11.3)
All causes of death 50.5 (100) 68.3 (100)
Data in millions and % in parentheses [8].
COPD: chronic obstructive pulmonary disease.
1.2.1. The burden of respiratory diseases in children
1.2.1.1. Incidence and prevalence of respiratory diseases
Despite advances in the understanding of the epidemiology of respiratory disorders in 
infants and young children, acute respiratory infections remain the commonest illnesses of 
childhood. The most frequently reported long-term illnesses in British children are conditions 
of the respiratory system, affecting 138 per 1000 in the 2-10 year old group [12]. In Britain, 
respiratory illnesses (both acute and chronic) account for 20% of weekly consultations 
between general practitioners (GPs) and children aged  0-14 years, with another 2% being 
for symptoms and signs involving respiratory disease [12:17]. Across this age range, the 
highest number of consultations is for upper respiratory tract infections (URTI) (Figure 1.1a). 
The peak incidence for URTI is at 6-12 months of age, with a second peak at around age  
3-5 years, presumably reflecting attendance at day-care centre, nursery or school. 
Bronchiolitis is the commonest lower respiratory tract illness (LRI) in the under 1 year olds, 
and acute cough or bronchitis in the 1-4 year olds (Figure 1.1b) [12:17].
Asthma is the most common chronic disease in children and its prevalence has increased 
continuously during recent decades, particularly in Western Europe [8]. It has been  
suggested that this reflects changes in family size and life style [8:18]. The prevalence, 
causes, natural history and clinical presentation of asthma differ with age.
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Figure 1.1. M ean weekly incidence of GP visits for respiratory diseases in children, 
1999-2001.
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In addition, differences in sex, genetic background and environmental exposure also 
influence both inter- and intra-individual variability in signs and symptoms of this 
heterogeneous condition, with wheezing as its major clinical expression [19]. A "wheeze” 
has been described as a non-specific sign and symptom associated with restriction of 
airflow through narrowed airways, which is thought to be initiated by turbulent flow 
causing oscillation of the bronchial walls, resulting in the characteristic high pitch, 
polyphonic ‘whistling’ sound [20].
The most recent figures for asthma across Europe, as reported from Phase I of the 
International Study of Asthma and Allergy in Childhood (ISAAC) and European Community 
Respiratory Health Survey (ECRHS) studies, suggest that the UK has the highest prevalence  
of asthma, being 20.7% in 13-14 year olds com pared with 1.6% in Albania, and 22.9% 
am ong 6-7 year olds versus 1.4% in Estonia [8:21 ;22]. Currently, 24/30 study centres have  
com pleted fieldwork for Phase II of fhe ISAAC sfudy, which aims to identify determinants of 
the observed differences in prevalence rates, including the role of atopic sensitisation and  
bronchial responsiveness, and the influence of indoor exposures and lifestyle factors [23]. 
In England and Wales, weekly GP consultation rates for acute asthma among both 0-4 
year olds and 5-14 year olds have fallen rapidly in recent years (Figure 1.2), possibly 
reflecting increased use of prophylactic anti-inflammatory therapy and improved 
treatment for acute asthma [8:24], In the recently published Aberdeen survey, 3,537 
parents (84%) completed questionnaires on behalf of their children (around 9-12 years old) 
who attended primary schools that had previously participated in studies in 1964, 1989 
and 1994. Findings with respect to respiratory symptoms suggested that the prevalence of 
childhood asthma appeared static betw een 1994 and 1999 [25]. However, reports from 
two further large surveys, conducted as part of ISAAC, in the UK (in 12-14 year old children 
during 1995-2002) and Melbourne (in 6-7 year olds between 1993-2002), respectively, 
provided evidence for an overall reduction in the prevalence of symptoms of asthma 
and/or atopy [26;27].
In most European countries, asthma mortality is low in children and decreases in later years
[8]. The high prevalence of this condition nevertheless has a considerable im pact on 
quality of life issues for children and their families, and places an economic burden on the 
health care services. Longitudinal population-based studies that followed up children from 
infancy or early childhood into adolescence and adulthood have improved our 
understanding of asthma [3;5;6;28-30]. Although most wheezing LRI commences during 
the first three years of life, it may be extremely difficult to distinguish viral-associated 
wheezing from childhood asthma in the pre-school child [31-33].
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Figure 1.2. Mean weekly incidence of asthma GP episodes in children.
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1.2.2. Phenotypes of childhood asthma
By recruiting healthy newborn infants, the prospective on-going longitudinal population- 
based Tucson Children's Respiratory Study (TCRS) has enabled identification of three 
phenotypes in children with asthma, namely: transient wheezing (up to 3-5 years of age  
but not thereafter); non-atopic wheezing of toddlers and children of pre-school age, and  
immunoglobulin E (IgE)-mediated wheezing [5]. Asthma phenotypes reflect a 
heterogeneous group of conditions, as determined by both genetic makeup and  
environmental influences, which is characterised by recurrent airway obstruction [34] and  
the three phenotypes in children are depicted in Figure l .3. Although flow-limitation can  
occur without audible wheeze, expiratory wheezing is always a sign of expiratory flow- 
limitation [35].
32
Figure 1.3. H y p o th e tic a l y e a r ly  p e a k  p re v a le n c e  of w h e e z in g  a c c o rd in g  to  
p h e n o ty p e s  in c h ild h o o d .
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1.2.2.1. Transient early wheezing
In early life, wheezing is generally episodic and  occurs during viral infections of the 
respiratory trac t [5]. Children with transient wheezing are more likely to have dim inished 
lung function early in in fancy [3]. Prematurity [36], prenata l [l;37;38] and postnata l [39:40] 
exposure to to b a c c o  smoke, and exposure to siblings or children a t dayca re  centres [41] 
are all risks factors for transient wheezing. These observations are consistent w ith reports 
from Perth [4:42] and London [1:37],
1.2.2.2. Non-atopic w heezing
Recent reports suggested tha t children w ho present w ith in term ittent wheezing during the 
first years of life and w ithout a significant fam ily history of asthma a n d /o r allergies are most 
likely to remit a fte r 10 years of age  [5:32:43:44], Respiratory syncytial viral (RSV) infections 
and pneum onia tha t occurred before three years of age  are associated w ith an 
increased risk of deve lop ing  asthma-like symptoms during school years, independen tly  of 
family history of asthma or a topy  [5:45]. However, the risk decreased with a ge  and  was no 
longer significant by 13 years [5], suggesting tha t RSV associated LRIs were not associated 
with an increased risk for a llergic sensitisation or higher tota l serum IgE levels [34],
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1.2.2.3. Atopic w heezing/asthm a
Analysis from the Tucson study suggested tha t am ong  children w ho wheezed w ith LRIs in 
the first three years of life, approx im ate ly  60% continue to wheeze and were a to p ic  a t 6 
years [3]. Children w ho were still sym ptom atic  a t 6 years of age  had experienced  more 
wheezing episodes in early life than those whose symptoms had ceased by three years. 
They had  more symptoms even w ithout a pp a re n t viral infection, and were more likely to 
have a to p y  and  to have mothers w ith asthm a than children with transient wheezing or no 
w heezing [3]. Am ong these children, there was a significant association be tw een  an early 
onset of wheezing symptoms and  severity of disease and airway responsiveness [5:34], It 
has been  suggested tha t early a llergic sensitisation increases the p reva lence of respiratory 
symptoms, chronic a irway in flam m ation and  the risk of changes in airway physiology and  
dec lin ing  respiratory function early in life [3:46-48].
1.2.3. Hospital admissions
Table 1.2 lists ch ildhood hospital admission rates for LRI in England. In 2000/2001, 15% of all 
children's hospital admissions in England were re la ted  to respiratory disease. Almost a third 
of all lower respiratory admissions in children and  40% in the 1-4 year olds w ere due to 
asthma, w ith croup and pneum onia also being im portant causes in the under 5 year olds. 
In contrast to the rising trend for asthm a admissions in the 1970s and  1980s, there has been 
a rap id  dow nw ard  trend in admissions for asthm a during the last d eca d e , w h ich  parallels 
the decline  in episodes of new asthm a in GP surgeries (Figure 1.2) [12]. This m ay in d ica te  
im proved trea tm ent since there has been an a ccom pa n y ing  increased use of an ti­
in flam m atory drugs [49], The second com m onest cause for admission in all ch ildren is 
acu te  bronchiolitis, w hich peaks in w in ter and  a ffects almost exclusively the very young. 
The high admission rate for the under 1-year olds for bronchiolitis is shown in Table 1.2.
Neonatal admissions are primarily re la ted  to the consequences of prem aturity. In England 
& Wales, m any preterm  infants have associated respiratory disease. In 2000, for exam ple, 
respiratory disease a ffe c ted  4,200 per 100,000 live born infants, of w hom  approx im a te ly  
one third were due to respiratory distress syndrome of the new born [12]. Those bom  very 
prem ature ly are a t particu la r risk of deve lop ing  CLDI or bronchopu lm onary dysplasia (BPD) 
[50-55], which remains a com m on cause of severe m orbid ity and  mortality. In England and  
Wales in 2000, there were 2,335 neonata l deaths, w ith diseases of the respiratory system 
a cco u n te d  for one third of these [12]. Beyond the neonata l period, most respiratory 
illnesses involve the airways rather than the parenchym a.
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Table 1.2. Hospital admission rates for lower respiratory diseases in England, 
April 2000-March 2001
Per 100,000
<1 1-4
Age in years 
5-9 10-14 All children
Asthma 179 559 211 135 272
Acute bronchiolitis 3,611 73 1 0 240
Pneumonia 373 246 55 24 113
Unspecified acute LRI 402 230 43 23 106
Croup 299 253 33 5 96
Cystic fibrosis 38 29 34 54 40
Acute bronchitis 48 12 2 1 7
Empyema 10 5 3 2 4
Bronchiectasis 3 2 2 2 2
Respiratory tuberculosis 4 2 0 2 2
Interstitial lung disease 3 2 0 0 1
Total 4,967 1414 385 249 882
Figures quoted for age categories are per 100,000 (Adapted from LAIA [12]) 
Definition of abbreviation: LRI: lower respiratory infections.
1.2.4. Mortality due to respiratory diseases
Deaths due to respiratory conditions in children (excluding neonates) in England & Wales 
in 2000 are shown in Figure l .4. Over the age range between 0-14 years, pneumonia was 
certified as the cause of death four times more frequently than asthma (Figure l .4). Three 
quarters of deaths from pneumonia occurred in the under 4 year olds, whereas 13 (60%) of 
the total of 22 asthma deaths in England and Wales occurred in children aged 10-14 
years.
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Figure 1.4. The number of deaths in children (excluding neonates) due to respiratory 
causes.
England & Wales 2000
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1.2.5. Paediatric origins of adult respiratory disease
Numerous publications are available regarding the developmental origins of adult 
respiratory disease. An association identified by Barker and colleagues between birth 
weight and cardiovascular disease has led to the concept of ‘programming1 - the 
permanent alteration of the structure and function of organs and tissues by factors 
operating during sensitive periods in fetal and early postnatal life [56], This concept has 
been used to explain associations between impaired fetal growth and risk factors for adult 
lung function, respiratory morbidity and death from COPD [57] and, more specifically, the 
association between early lung growth and chronic airflow obstruction [58]. From studies in 
North Hertfordshire, it has been postulated that early under-nutrition results in impaired 
development of molecular and cellular repair mechanisms which may affect all tissues but 
which are most critical in later life [59],
Similar investigations were conducted in two British national cohorts. Data from the 1946 
birth cohort study suggested that LRI in the first two years of life was a significant risk factor 
for adult chronic obstructive pulmonary disease. Birth weight, overcrowded home 
circumstances at two years of age and a parental history of bronchitis were each  
independently associated with reduced peak expiratory flows at age 36 years, even after 
adjusting for smoking, level of education and social circumstance in adult life [60;61].
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Incidence and prognosis of asthma and wheezing illness and their relation to perinatal 
factors were investigated in the 1958 cohort from birth to age 33 years. The incidence of 
wheezing during childhood was strongly and independently associated with pneumonia, 
hay fever and eczem a, while that in young adults (17 to 33 years) was also strongly 
associated with a history of hay fever. Those with a history of wheezing illness in childhood 
were also shown to retain a risk of wheezing in adult life, above that of their healthy peers 
[62],
Factors implicated in programming are discussed later (section 1.5) and include fetal 
growth, nutrition, exposure to maternal smoking and family history of asthma. It is likely that 
outcom e is determined by a combination of genetic, environmental and familial factors 
and that these factors will influence the interpretation and longer-term implications of 
respiratory function measurements during infancy and early childhood.
1.3. GROWTH AND DEVELOPMENT OF THE RESPIRATORY SYSTEM
Lung development occurs primarily during fetal life, a time when the lung is not required to 
fulfil its extrauterine function in gas exchange but has to function efficiently immediately 
after birth. It has been suggested that the pattern of lung growth is genetically determined  
[63]. However, several intrauterine environmental factors have been recognised as 
important modulating influences, including fetal breathing movements (with respect to 
changes in thoracic dimensions) [64;65], quantity of fetal lung liquid, its rate of secretion 
and absorption [66:67], maternal alcohol [68] and nicotine [69-71] intake, prenatal 
glucocorticoid administration [72] and infection [73:74]. While drainage of amniotic fluid 
as a result of premature rupture of membranes may lead to lung hypoplasia [75], 
restricted intrathoracic space, as in congenital diaphragmatic hernia and  
oligohydramnios, leads to a reduction in airway number [76:77]. Insulin-like growth factor 
promotes multiplication of epithelial cells, whilst transforming growth factor (5 inhibits 
multiplication but enhances protein synthesis [78]. In addition, data  from animal models 
suggest that maternal malnutrition may inhibit lung growth [79]. Further details of factors 
influencing early lung growth and developm ent will be presented in section 1.5.
There is increasing recognition that the level of airway function may be established during 
fetal development and the first year of life, with little subsequent improvement through the 
normal repair process [3:80:81]. Adverse events during fetal development and infancy 
may therefore have long-term and irreversible effects throughout life [82-84]. Since airway 
structure and function may be dependent on normal growth and development of the 
lung during early life, awareness of the sequence and timing of the major developmental 
changes is an important pre-requisite to understanding respiratory disease and its
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treatment. Crucial to this understanding is the concept that the lung is not a mature organ 
at birth. The growth and developm ent of the respiratory system is summarised in the 
following sections.
1.3.1. Early lung and airway development
The stages of human lung growth are listed in Table l .3. Lung development begins in the 
4th week after conception with a simple diverticulum of the foregut and lobar bronchi at 
the 5,h week of gestation [63:85]. Based on the appearance of the lung tissue, lung growth 
has been classified into 4 phases, namely the embryonic, pseudoglandular, canalicular 
and alveolar periods. Each of these phases has a specific duration and each gradually 
evolves into the next phase (Table 1.3) [63:85]. The alveolar phase may be further divided 
into the early saccular or terminal sac stage and a later alveolar stage, which continues 
after birth in infants. There is considerable variation in the time span for lung developm ent 
betw een different individuals and species [63]. An important event to note is that the full 
number of generations of conducting airways to the level of the terminal bronchioli is 
established by the 16,h or 17th week of gestation [86]. Hence, the occurrence of any 
adverse events during the first half of the pregnancy may result in reduced numbers of 
airway generations. By further division, nearly all the respiratory airways are present at birth. 
By about 24 weeks gestation, type II cells in the respiratory region are capab le  of 
producing surfactant [63] and by 26 weeks, airway wall structure is mature [87:88]. 
Although gas exchange is feasible earlier (as witnessed by the survival of some extremely 
preterm infants from about 23 weeks gestation onwards), mature alveoli that are cup­
shaped with a single capillary layer do not appear until approximately 28-30 weeks of 
gestation. By term (40 weeks post-menstrual age [PMA], where PMA is the sum of 
gestational and postnatal age), potential gas-exchanging surface has increased 
markedly, the interstitium has thinned and the capillary network expanded, resulting in 
increased capillary volume and diffusing surface. This increase continues up to 18 months 
postnatally [89]. Since fetal lung developm ent appears to be highly sensitive to the 
intrauterine milieu, this may explain the wide range of alveolar number present at birth. 
The alveolar stage is followed by an additional and final stage in lung development, that 
of microvascular maturation [90:91]. In the human lung, rapid alveolar multiplication 
occurs during the last few weeks of intrauterine life and particularly the first few years of 
postnatal life.
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Table 1.3. Stages of human lung growth
Phase Gestation Major events
Embryonic period 4 - 7  weeks lung buds and segmental bronchi develop; epithelial tube appears, divides and grows into 
surrounding mesenchyme; vascular connections appear
Fetal period
Pseudoglandular 6-17 weeks Conductive airway tree develops in parallel with formation of vascular tree; smooth muscle cells 
present in trachea and lobar bronchi; cartilage plate appears in the trachea; epithelial lining cells 
differentiated into ciliated and goblet cells
Canalicular 16-27 weeks intra- acinar (respiratory) airways develop; thinning of peripheral epithelial and mesenchyme; 
peripheral airways continue to divide forming prospective respiratory bronchioli and alveolar ducts; 
differentiation of type 1 and II pneumocytes cells & start of surfactant production; formation of distal 
pulmonary circulation
Saccular/alveolar 26 weeks to term Formation of additional airway generations and alveoli; development of single-layered capillaries 
network lining saccules and alveoli; prospective gas exchanging airspaces dilate; maturation of 
surfactant system
Postnatal period
Alveolar Birth to 18 months Formation of alveoli by outgrowth of secondary septa; symmetrical airway growth; small blood 
vessels multiply
Arteries & veins Birth -  3 years Reduction of double capillary network to single-layered network; reduction of interstitial tissue mass, 
fusions of capillaries, preferential growth of single-layered capillary network areas
Up to adulthood All structures increase in size
Adapted from Burn [85] and Hisplop & Pandya [90].
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1.3.2. Postnatal lung and airway growth
Considerable remodelling of the lung occurs after birth [92]. Each of the structural 
components -  airways, alveoli and blood vessels -  has a different pattern of growth with 
respect to increase in number as well as size [93]. At birth, the airways are fully innervated 
and approximately 150 million alveoli, equivalent to >/3 to ]h  of the adult number, are 
present [94;95], with the blood gas barrier being of the same thickness as in the adult. In 
humans, alveolarisation is mainly a postnatal event, since approximately 50-80% of mature 
alveoli are formed after birth [85;96]. Lung growth occurs by alveolar multiplication and  
increase in tissue mass. By 6 months of life, a large proportion of the human lung appears 
mature in that many parenchymal septa no longer exhibit the double capillary network 
needed for the formation of new inter-alveolar walls. The question of the duration of the 
stage of alveolar formation has been much debated. In the human, a relatively rapid 
process (or 'bulk alveolar formation') starts around one month after birth but by 6 months, 
the intensity of alveolar formation has decreased [85;95]. At this age, numerous inter- 
alveolar walls and, by 1V2 years, most septae, are at least partially of the mature type [85]. 
It has been suggested that human alveolar development may be virtually com plete by 2- 
3 years of age [63;97]. After this, alveolar growth is by enlargement only [98]. In the first two 
years after birth, alveoli multiply with their accom panying arteries and veins. By 5 years of 
age, the lung has been found to correspond morphologically to a miniaturised adult lung 
(85].
The resting volume of the lungs increases from around 90 mL at birth in a term infant to 
3,000 mL in adulthood [92;99], with lung weight increasing from 60 to 750 g over this period 
[100]. Lung size continues to increase at least until growth of the chest wall is com plete  
[93]. The number of conducting airways is com plete at birth, with airways only increasing in 
size postnatally [93]. These airways increase in diameter and length by two to three times 
between birth and adulthood [87] with growth occurring in a symmetrical manner, in a  
constant relation to the rest of the lung [87:101]. At birth, there is relatively less airway 
smooth muscle than in the adult [87:102]. During the first year of life, there is a rapid 
increase in both sub-mucosal glands and airway smooth muscle within the airway wall, 
relative to the more gradual, symmetrical, increase in airway length and diam eter [101]. 
The increase in airway smooth muscle is particularly marked during the first weeks after 
birth and by 8 months of age, the relative proportion of muscle within the bronchioli is 
similar to that of adults. Within the larger airways, the proportion of airway smooth muscle 
continues to increase beyond infancy and therefore, during infancy, there is relatively 
more muscle within the small non-cartilaginous airways than in the bronchi [87]. The 
stimulus for rapid development of airway smooth muscle shortly after birth has been
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attributed to the onset of air breathing [87]. An increase in the quantity of airway smooth 
muscle is seen in preterm and ventilated infants [87] as well as in children with a history of 
bronchiolitis [102]. The functional consequence of this is a greater increase in resistance in 
the small airways for a given amount of smooth muscle shortening. This is because airway 
calibre is one of the major determinants of airway resistance (Raw), the latter being 
inversely proportional to the 4th power of the radius (Poiseuille’s law) [103]. Thus, if the radius 
is halved, resistance increases by a factor of 16 whereas doubling the length of a tube 
only results in a  2-fold increase. Pulmonary inflammation and infection in infancy, though 
not affecting airway number, may have effects on airway growth resulting in diminished 
airway calibre. Stimulation provided by stretch may continue to influence lung growth 
after birth, since diaphragmatic and regional muscle activities have been reported to 
determine parenchymal growth by proliferation [104].
1.3.3. Dysanapsis
In the human, marked differences may exist in the relative size of the lungs and airways 
between individuals of similar age, height and sex. The term dysanaptic, or 
disproportionate (but physiologically normal), growth of the lung and airways has been  
used to explain the inter-subject variability in expiratory flow which can only be partly 
accounted by differences in lung elastic recoil or lung volume [105; 106]. The disassociated 
growth patterns of the airways and parenchym a during fetal and early life result in airways 
that are relatively large in relation to lung volume at birth [83]. This is supported by the 
finding of relatively lower airway resistance at birth than at two to three months of age  
[107:108]. In another study in which FRC and maximal forced expiratory flows during the 
tidal breathing range were assessed in healthy infants, Tepper e t  a l concluded that 
neonates have larger airways relative to their resting lung volume than older children 
[109]. A recent study using an infant lung model supported this finding [110]. Other studies 
have also provided evidence that dysanaptic growth occurs at least in the first few years 
of life [111:112] and again during adolescence [113]. The rate constant derived from 
forced expiratory manoeuvres, a measure of lung emptying, has been shown to be  
approximately four times greater in young infants than in adults [114].
By contrast, on the basis of the extent to which measurements of forced expiratory flow 
'track' throughout childhood, and the fact that volume-adjusted flows correlate well 
within individuals with increasing age, Hibbert e t  a l suggested that the relative rate of 
growth of different parts of the lung remains constant relative to one another at least 
between mean ages of 9 to 18 years [115]. However, from longitudinal d a ta  analysis, 
Merkus e t a l concluded that airways and airway spaces continue to grow isotropically (or
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proportionally in all directions) in boys during adolescence, whereas in girls, airway growth 
lags behind that of the parenchyma during this period [116).
1.3.4. Increased vulnerability to respiratory illnesses
Hospital admission rates for lower respiratory diseases in infants and children demonstrate 
the marked increased vulnerability to LRIs during the first year of life (Table l .2). This may 
be largely attributed to a combination of having airways that are small in absolute size 
and a relatively immature immune system. In addition, in infants, the tendency for 
dynamic closure of peripheral airways towards end-expiration during tidal breathing 
[83; 117] increases their susceptibility to airway obstruction and wheeze in the presence of 
respiratory disease [118]. Willet and Sly [119] interpreted the differing patterns of wheezing 
illnesses, or phenotypes (section 1.2.2), expressed at different ages as an indication of the 
importance of dysanaptic growth. In the first 2 years of life, viral LRI can cause widespread 
airway obstruction, hyperinflation and wheezing, whereas in later childhood, the airway 
obstruction associated with viral LRI tends to be less severe and hyperinflation less 
common [119]. This difference may partly be explained by the increasing m echanical 
interdependence of the airways and air spaces with growth, which leads to increasing 
traction or "pull" on the peripheral airways, thereby ‘enlarging’ their calibre and  
diminishing the risk of wheezing [120].
The major aspects of developmental respiratory physiology which differentiate infants from 
adults, together with factors that may influence the growth and function of the respiratory 
system in early years, are presented in the next section.
1.4. DEVELOPMENTAL RESPIRATORY PHYSIOLOGY
In health, many parameters of respiratory function remain remarkably constant when  
related to either body size or surface area, reflecting the fact that respiration must remain 
closely attuned to the metabolic requirement of the body. However, the underlying 
factors determining these parameters may vary considerably according to age  
[83;84;l2l]. Interpretation of respiratory function measurements during infancy may be  
confounded by many factors, such as age, size, ethnic background, sex and  
environmental exposures. The rapid somatic growth that occurs during the first year of life 
is accom panied by major developmental changes in respiratory physiology, particularly 
with respect to the influence of control of breathing, the upper airways, dynamic 
elevation of FRC and chest wall compliance. An understanding of developmental 
respiratory physiology is essential to the success of measurements and interpretation of 
respiratory function data  in this age group.
42
1.4.1. Transition to extrauterine breathing
Despite many anatom ical similarities, the respiratory system in early life is by no means 
simply a miniaturised version of that of an adult. Within the first few minutes of birth, in order 
to establish efficient gas exchange, newborn infants must rapidly switch from intermittent 
fetal breathing movements, which play no role in gas exchange, to a continuous rhythmic 
respiratory pattern. Simultaneously, the respiratory system undergoes dramatic functional 
changes, such as clearance of lung liquid, rapid aeration of the lung, redistribution of 
blood flow and establishment of a resting lung volume. These changes are accom panied  
by a rapid rise in compliance and decrease in resistance, with relatively stable values 
being achieved within the first 12-24 hours after birth [122]. Blood gas and acid-base  
balance rapidly adjust to a steady state within the first few hours after birth [123].
To achieve effective ventilation at birth, the lungs must be developed to a stage where 
the alveoli can be inflated, and the forces opposing this must be overcome. Once regular 
respiration has been established, alveolar ventilation, minute ventilation and gas mixing 
efficiency are similar to that of an adult, once allowance has been m ade for differences 
in body size and metabolic rate [83]. However, the relatively large surface area to body 
mass ratio and rapid growth in infants are associated with relatively high oxygen 
consumption and metabolic rate when com pared with those in adults [124]. The 
increased minute ventilation in relation to body size that is required to m eet this increased 
dem and for oxygen in early life is achieved primarily fhrough an increased respiratory rate 
during the first months of life, with weight corrected tidal volume remaining relatively 
constant [99].
1.4.2. Control of breathing
Respiratory control and lung function undergo a series of inter-related dynamic changes 
during growth and development. These im pact on measurements as well as interpretation 
of results, as outlined below.
1.4.2.1. Chemo-reflexes
Important differences in respiratory reflexes in young infants are related to maturational 
differences in chemo-sensitivity. Af birth, chem oreceptor activity to hypercapnia is strong, 
whereas the hypoxic response is relatively weak, varying from a biphasic response with an 
overall decrease in ventilation during the early neonatal period to modest increases with 
advancing age [125;126]. Prematurity, intrauterine growth restriction, fetal exposure to 
maternal smoking during pregnancy and perinatal hypoxia have all been associated with
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a diminished hypoxic and arousal response in young infants, thereby increasing their 
respiratory vulnerability [118:127-132].
1.4.2.2. Vagal mechano-reflexes
In I960, Cross e t a l demonstrated the occurrence of apnoea following lung inflation, in 
newborn infants [l 33]. This apnoeic pause, or prolongation of expiratory time, was 
reported as the manifestation of inhibition of inspiratory effort as a result of stimulation of 
the pulmonary vagal stretch receptors, namely, the Hering-Breuer inflation reflex (HBIR) 
[134:135]). The original report was the first recognition of a self-steering regulatory 
mechanism or negative feedback for respiratory control [136]. In 1974, Younes e t  a l 
confirmed that the apnoeic pause subsequent to lung distension was usually associated 
with relaxation of the respiratory muscles [137].
Three types of pulmonary receptors are regarded to be involved in vagally m ediated, 
volume-related reflex control of breathing: slowly-adapting (stretch) receptors (SARs), 
rapidly-adapting (irritant) receptors (RARs) and pulmonary C-fibres [138]. SARs are 
responsible for the HBIR [139-142]. These receptors are located within airway smooth 
muscle and epithelial layers from the trachea to bronchioles, the concentration of which is 
greatest in the larger airways, decreasing progressively towards the terminal bronchioles 
[138:143:144]. In response to airway stretch (i.e., during lung inflation), they a d ap t slowly to 
the stimulus and provide an inspiratory off-switch once a certain volume threshold is 
reached, thus determining respiratory rate and depth [145].
It has been generally recognised that the HBIR is stronger and much more physiologically 
active in the newborn period and during infancy than in adult life, since a prominent reflex 
response has been observed in healthy infants during natural sleep within and above the 
tidal volume range [133:146-149]. It has also been recognised that the vagally m ediated  
HBIR plays an important role in regulating the rate and depth of respiration in newborn 
mammals during the first weeks of life [150-152]. After birth, in both term and preterm  
infants, m echano-receptor activity is important in the maintenance of lung volume 
[146:153]. The presence of an active HBIR during tidal breathing in infants has facilitated 
measurements of passive respiratory mechanics in this age group, whereby airway 
occlusions at end-inspiration evoke a brief expiratory pause with muscle relaxation, during 
which, in the absence of flow, pressure equilibrates within the respiratory system allowing 
elastic recoil pressure to be measured at the airway opening. More recently, the ability to 
invoke HBIR has been used to evoke respiratory muscle relaxation and facilitate com plete  
expiration during the raised lung volume technique [154] by delivering several augm ented  
breaths prior to forcing expiration (section 1.10.2).
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Another important aspect of the vagal mechano-reflex is with respect to the control of 
breathing. This is demonstrated when, in the presence of a reduced lung volume, 
expiratory time is reduced and respiratory rate increased in order to dynamically elevate  
resting lung volume. Further details of this mechanism are presented in section 1.4.5.
1.4.3. Influence of the chest wall
The highly compliant chest wall of the infant results in relatively low transpulmonary 
distending pressure when com pared with older subjects [l 55]. The reduced outward recoil 
allows the lungs to deflate to relatively low lung volumes at the end of a passive expiration 
resulting in less tethering traction on the airways, and a tendency for peripheral airways to 
close at end-expiration. This not only impairs gas exchange and ventilation-perfusion 
balance, particularly in the dependent parts of the lungs [l 56] but, together with the 
absolute small size of the airways, renders infants and young children highly susceptible to 
airway obstruction and wheeze. In addition, the inability of the floppy chest wall 
(particularly in those born prematurely) to withstand normal negative intrapleural swings 
can lead to asynchronous movements of the rib cage  and abdom en during inspiration, 
resulting in a less efficient system whereby the respiratory muscles expend energy not only 
in exchanging tidal volume but also in distorting the rib cage, resulting in fatigue [l 57]. 
Furthermore, the relative paucity of Type I skeletal muscle (slow twitch, high oxidative 
fibres) contributes to the further reduction of efficiency of the respiratory pump and  
increases the risk of developing respiratory fatigue [158,159]. The chest wall undergoes 
major structural and functional changes in the first five years of life [157]. During this period, 
ossification of the ribs, vertebrae and sternum lead to significant increase in chest wall 
rigidity with growth [157:160].
1.4.4. Upper airways
Nasal resistance comprises approximately 50% of total airway resistance at all ages [161]. 
Since infants are preferential nose breathers, the upper airways may have a major 
influence on the conduction of air to and from the lungs, particularly in the presence of 
upper respiratory infections [162]. For this reason, infant lung function tests should be  
delayed for at least 3 weeks following the onset of any respiratory infection. The role of the 
upper airway in modulating expiratory flow to preserve lung volume is described in the 
following section.
1.4.5. Dynamic elevation of end-expiratory level
Optimal pulmonary gas exchange requires an adequate  resting lung volume or functional 
residual capacity (FRC). In order to overcome the potential difficulties imposed by their
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highly compliant chest wall, infants tend to defend their lung volume by dynamically 
elevating the end-expiratory level, such that they breathe in before the passively 
determined FRC is reached. The emptying time of the lung, under passive condition, can  
be described by the expiratory time constant (t) of the respiratory system, which is defined 
as the time taken for the lung to deflate passively in an exponential fashion to 37% of its 
original volume [163]. Three expiratory time constants are required to achieve 95% of lung 
emptying, t is determined by the product of compliance and resistance. Stiff lungs (low 
compliance) will have a short t and will empty and fill rapidly, whereas in the presence of 
high airway resistance, t will be elevated and the lung will empty and fill slowly. Dynamic 
elevation of FRC occurs whenever the expiratory duration is less than three expiratory time 
constants. This may occur as the result of a rapid respiratory rate (i.e., short expiratory time) 
and/or an elevated airway resistance (increased t) [164]. While pathological signs of 
hyperinflation may occur in infants with airway obstruction (asthma, bronchiolitis and  
cystic fibrosis), the phenomenon of dynamic elevation also occurs to a lesser extent 
among healthy young infants as a means of defending their FRC in the presence of a  
highly compliant chest wall [ 164; 165].
During the first months of life, infants modulate expiratory flow using upper airway 
adduction and post-inspiratory diaphragmatic muscle activity to "brake" or slow 
expiratory flow, thereby lengthening the expiratory time constant of the respiratory system 
[164:166-169]. In addition, control of respiratory timing is m ediated through tonic and  
phasic vagal stretch receptors which are exquisitely sensitive to changes in resting lung 
volume [170]. During the application of continuous negative or positive airway pressure, 
the instantaneous change in respiratory rate and pattern can be seen in response to small 
changes in resting lung volume [171]. Infants frequently exhale passively to a lower lung 
level (i.e., their "true" resting lung volume) during an apnoeic pause when the expiratory 
time is prolonged. Although the ability to modulate expiratory flow and timing is 
physiologically beneficial to the infant, this can complicate attempts to assess respiratory 
function. The variability of the end-expiratory level may hinder the assessment and  
interpretation not only of lung volumes, but also of respiratory mechanics and forced 
expiratory flows, since these indices are highly volume dependent [172].
It has been suggested that a shift from active to passive maintenance of FRC does not 
occur until the end of the first year of life, after which passive characteristics of the lung 
and chest wall are likely to determine resting end-expiratory lung volume as in older 
subjects [173].
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1.5. FACTORS INFLUENCING LUNG GROWTH AND FUNCTION DURING 
INFANCY
Besides developmental differences in respiratory physiology, several factors are known to 
influence respiratory function in early life. These include -
1.5.1. Sex
Several investigators have reported differences in airway function and prevalence of 
respiratory illness during infancy and childhood according to the sex of the individual 
[84; 113; 174-180]. Although there appear to be no sex differences in the relationship of lung 
to somatic growth in utero, it has been reported that enhanced lung maturation has been  
observed in female compared to male fetuses both with respect to mouth movements 
[181] (a marker of fetal breathing that is thought to be a critical determinant of fetal lung 
development) [64; 182] and phospholipid profiles (a marker of surfactant production) 
[183; 184]. The higher degree of lung maturity in female than in male fetuses during the last 
two months of normal pregnancy may contribute to the higher reported incidence of 
respiratory distress syndrome (RDS) among male preterm neonates [183;185].
Functional studies have suggested that during both infancy [42; 178; 186-189] and up until 
puberty [ 116; 180; 190; 191], girls have higher forced flows in relation to lung or body size 
than boys suggesting that airway calibre is greater in girls than in boys. This may be a  
contributory factor for greater severity [5] and higher prevalence of wheezy LRI and  
asthma observed in boys during both infancy [5;37] and childhood [5; 192]. Another study 
has reported that sex differences in airway structure and responsiveness are present soon 
after birth, representing differences in fetal lung development and are associated with 
differences in the risk of subsequent LRI with wheezing [178]. Evidence also suggests that 
during childhood, boys have greater resting airway tone than girls and that this tone is less 
responsive to deep inspiration and isoproterenol (a (32-agonist) [193].
Enhanced airway growth has been reported in adolescent males [111; 179] which may 
partly explain the greater clinical improvement in males than in females with respect to 
respiratory disease as they becom e adults [116; 194; 195]. Recent evidence, however, 
suggests that relative to females with asthma, males with asthma are twice as likely to 
develop airway remodelling by 18 years [196] and have a lower FEVi/FVC ratio at 26 years 
[30].
The implication of the biological differences between the sexes should be taken into 
consideration when interpreting respiratory function, particularly during rapid phases of 
growth and development [42; 180].
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1.5.2. Ethnic origins
Several studies have reported marked ethnic differences in infant mortality and respiratory 
morbidity. Although black infants have a higher risk of neonatal and postnatal deaths than 
white infants, among low birth weight infants, neonatal mortality is lower in black infants 
[197;198] who are also less likely to develop respiratory distress syndrome (RDS) than white 
infants of similar gestational age [l 99]. These relationships appear to persist even after 
allowing for socio-economic status [l 98] which suggests that the respiratory system is more 
mature or that airway function is enhanced in black preterm infants [200].
Ethnic differences in breathing patterns and respiratory mechanics have been observed 
during early life. Relative to white infants, black infants have lower airway resistance [161], 
lower respiratory rate, longer expiratory time and higher weight-corrected compliance of 
the respiratory system [189:201]. Maximal forced expiratory flows at FRC (V 'm axFRc) and the 
duration of time to reach peak tidal expiratory flow as a proportion of total expiratory time 
(tpTEFitE; an index of tidal expiratory flow pattern reflecting the control of lung emptying 
during expiration) are significantly lower in white com pared with black infants [189:201]. 
This may reflect a transient difference in measurement of flows at a slightly higher end- 
expiratory lung volume among black infants due to their different pattern of breathing, 
with more marked braking or slowing of expiration (longer tpTEF:tE) during the neonatal 
period.
By contrast, based on values predicted from standing height, lung volume and forced 
expiratory flows are lower in black adults and older children, whereas no such 
discrepancies are observed when respiratory function is related to sitting height [190:202]. 
These differences may primarily reflect ethnic variation in the trunk to height ratio 
[190:203].
In the USA, relative to white children, a higher prevalence of asthma (1.1-1.7 times) 
[195:204:205], hospital admission (2-3.5 times) [204:206:207] and mortality rate (2-5 times) 
[204:208] associated with asthma have been reported in Hispanic and African American 
children, emphasising the need to take both ethnic group and socio-economic factors 
into account when interpreting lung function tests and their relation to respiratory disease 
in childhood.
1.5.3. Early life factors and socio-economic status
Socio-economic factors have been widely investigated as a ‘fundam ental’ cause of 
disease and as such, may contribute to the trajectory of later disease over the life course 
[209:210]. A detailed review of this topic is beyond the scope of this thesis. It is generally
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recognised that modifiable factors such as nutrition and smoking are associated with poor 
socio-economic conditions. Other indicators of poor socio-economic conditions include 
variables such as level of income, overcrowded households, family size and parental 
separation and/or divorce. Several studies have suggested that deprivation in childhood 
influences risk of mortality from cardiovascular disease and respiratory function in later life 
[210-217]. However, far less is known about the influence of socio-economic status (SES) on 
lung health since fewer studies have considered SES as a confounding factor when 
examining respiratory function, particularly during infancy and early childhood [218].
Over the past decades, epidemiological studies have been enormously successful in 
identifying risk factors for major diseases. As early as 1934, a paper by Kermack e t  a l 
published in the Lancet hypothesised and discussed birth cohort influences regarding 
early-life exposures on adult diseases. Based on their analysis, they observed that "the 
expectation of life was determined by the conditions which existed during the child’s early 
years", and concluded that "the health of the child is determined by the environmental
conditions existing during the years 0-15, and ............ the health of the man is determined
preponderantly by the physical constitution which the child has built up" [219]. 
Interestingly, Kermack e t a l also suggested that infant mortality was dependent upon the 
health of the mother (i.e., intergenerational effect), and thus that improvement in infant 
mortality followed the generational improvement in the vitality of women of childbearing 
age. However, based on the pattern of cohort-related mortality during the period covered  
by these authors, namely 1860-1932, they explicitly rejected the argument that very early- 
life development (before or within the first year of life) could play any role in determining 
the mortality risk of birth cohorts as they aged . Other recent research, taking a lead from 
the original work of Forsdahl [220], has investigated the possibility that exposures acting  
right across the growth and developmental phase, from prenatal growth through to the 
end of adolescence, may importantly influence later health [61 ;210;214;215:218:221]. 
Some epidemiologists maintain that the importance of social circumstances early in life 
may be in the way they influence employment, social position and exposure in adulthood, 
and thus it is the adult, rather than childhood, circumstances which are more important as 
predictors of disease outcome [217]. However, others have suggested that an individual’s 
status for behavioural risk factors (exercise and smoking) is associated primarily with current 
socio-economic circumstances, while status for physiological risk factors (serum cholesterol, 
blood pressure, body mass index and FEVi) is associated to varying extents with both past 
and present socio-economic circumstances [211]. Although retrospective longitudinal 
analyses from cohort studies support the notion that SES may contribute to the trajectory 
of respiratory function over the life course, they are limited by an inherent problem: 
namely, that socio-economic circumstances in childhood and adulthood are linked, and
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the specific effects of socio-economic conditions in early life, as opposed to the 
continuing effects of deprivation throughout life, are difficult to isolate, and that the 
observed decline in lung function may be the result of several mechanisms [212:222].
It has been recognised that fetal and early life occurrences may prevent the lung from 
attaining its full potential, leading to increased risks of respiratory illnesses in later life 
[57:223]. A prospective study, reported in Chapter 4 of this thesis, was conducted to 
investigate the association betw een birth weight and airway function during infancy. 
Respiratory function d a ta  from this research was, in part, interpreted with SES as a  distal 
cause, which was m ediated by complex causal pathways including maternal smoking, 
nutrition, biological and environmental factors.
1.5.4. Fetal growth
Fetal or intrauterine growth retardation (IUGR) is associated with prematurity, intrauterine 
death and diminished fetal reserve during labour [224-227]. In a meta-analysis, the effect 
of birth weight has been attributed more to intrauterine growth retardation than to 
preterm delivery [228]. Cigarette smoking is the single most important factor affecting birth 
weight in developed countries [228], resulting in an average reduction of 150 to >300 g in 
infant birth weight [229-234]. Both maternal and paternal smoking are associated with low 
birth weight, with maternal smoking having the greater effect [235:236]. An improvement 
in infant birth weight has been demonstrated by reduction of smoking during pregnancy  
[237].
An increased risk of perinatal mortality and morbidity is associated with birth weight a t or 
below the 10th percentile for gestational ag e  [238-241]. During the first year of life, infants 
bom with low birth weight for gestational age (commonly referred to as small for 
gestational age [SGA]) are more likely to be admitted to hospital due, mainly, to 
respiratory tract infections [242]. Hospital admissions that are directly related to respiratory 
infections have been found to be significantly associated with maternal smoking at the 
time of conception, rather than postnatal exposure [243]. Since maternal smoking is also 
strongly associated with SGA births, the association between SGA and respiratory 
infections may be confounded by maternal smoking. Low birth weight has also been  
associated with wheezing in children up to 5 years old [244] and reduced respiratory 
function in later childhood [245]. However, there are no similar studies examining the 
effect of SGA on airway function in infancy [80]. It has previously been reported that SGA 
infants have accelerated pulmonary maturation and a reduced risk of respiratory distress 
syndrome (RDS), relative to infants of appropriate birth weight for gestational ag e  (AGA) 
[246:247]. However, findings from more recent studies challenged this concept of
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accelerated  pulmonary maturity and showed that, when com pared with AGA infants of 
the same gestational age, sex and ethnic background, SGA infants are at increased risk of 
death and respiratory illness [242:248]. The relative risk for RDS and respiratory failure 
associated with being SGA (odds ratio [OR]: 1.9: 95% confidence interval [Cl]: 1.2 to 3.2) 
was found to be of similar magnitude to that associated with male sex (OR: 2.0: 95% Cl: 1.2 
to 3.3) or white race (OR: 1.9: 95% Cl: 1.1 to 3.2) [248]. This is corroborated by findings from 
a research study forming part of this thesis, which is presented in Chapter 4.
Several studies have confirmed a strong association between intrauterine growth 
restriction (IUGR) and sudden infant death syndrome (SIDS), although the extent to which 
this might be confounded by factors such as maternal smoking is not always clear [249- 
253]. It has been suggested that adverse intrauterine conditions are more important 
because it is birth weight, rather than growth velocity in early postnatal life, that is reduced  
in infants who die suddenly and unexpectedly [254]. It has been suggested that many 
cases of SIDS may be due to a final episode of progressive peripheral bronchial occlusion, 
which would be more likely to occur in infants with pre-existing diminished airway function 
[118]. Thus, minor alterations in lung structural development during fetal life could have  
marked postnatal consequences, as fetal insults may also exert effect on postnatal 
growth. In the presence of subsequent respiratory infections, airway calibre may be 
critically reduced, resulting in severe, and potentially fatal, respiratory compromise.
Over the last decade, the idea that adult disease is determined in early life is most 
influentially reflected in the ‘fetal origins’ work of Professor David Barker and his colleagues. 
In this context, the critical period of early-life development, which is influenced by 
environmental exposures and has long-term effects on later health, is the intrauterine 
period [255]. Extensive investigations by this group led to the suggestion that adult diseases 
are m ediated by altered fetal nutritional status and defective perinatal growth 
[57:221:223:256:257]. The fetal origins hypothesis suggests that the structure and function of 
various organs in later life is "programmed" by impaired fetal nutrition or growth at critical 
periods of organ development [14]. This concept has been supported by evidence from 
animal studies [258-260]. Failure to reach growth potential during early life may be  
irreversible [56].
A population-based study, which formed part of the research reported in this thesis, was 
designed specifically to investigate the association between birth weight and airway 
function in early infancy and to explore the fetal origins hypothesis. Findings from this study 
are presented in Chapter 4.
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1.5.5. Maternal smoking during pregnancy
The hazardous effects of cigarette smoke exposure on the fetus, infant and child with 
respect to growth and development and respiratory function have been widely reported 
[l3;40;232;26l-265]. Cigarette smoke is composed of some 3,000 different compounds and  
the main components are carbon monoxide (CO), nicotine, polycyclic aromatic  
hydrocarbons (PAHs) and others such as cyanide and cadmium [266]. Prenatal maternal 
smoking affects the fetus in several ways that may result in chronic hypoxia and low birth 
weight for gestation.
The affinity of CO for haemoglobin is 250 times greater than that for oxygen. Furthermore, it 
dissolves readily in the plasma leading to impaired oxygen exchange in the tissues 
[13:267]. During pregnancy, the dissolved CO in maternal plasma crosses the placental 
barrier by passive diffusion, subjecting the fetus to great risk since fetal haemoglobin has a 
higher affinity for CO than adult haemoglobin. Similarly, nicotine crosses rapidly from the 
maternal to fetal circulation via the placenta, with fetal concentrations being around 15% 
higher than maternal levels. Cotinine, the primary metabolite of nicotine, has a relatively 
long half-life of 14 to 24 hours and is frequently used to provide an index of nicotine 
exposure [268-271]. Cotinine has been detected  in amniotic fluid as early as the 7th week  
of gestation in both active and passive smokers [272]. Throughout gestation, the fetus is 
exposed to increasing concentrations of nicotine through the maternal circulation and via 
gastrointestinal and skin absorption of nicotine from the amniotic fluid [273]. This is 
supported by the finding of significantly higher level of cotinine in the first urine from 
newborn infants born to smoking mothers com pared to those not exposed to the 
chemical by-products of tobacco smoke in utero  [274]. Placental vascular resistance is 
often increased when women smoke during pregnancy [275:276] and may result in 
placental dysfunction, impairing the transfer of nutrients to the fetus. The concomitant 
adverse effect of carboxyhaemoglobin on oxygenation, chronic exposure to CO and  
deprivation of nutrients in utero  may result in significant growth restriction [13:277:278]. The 
primary mechanism mediating the effect of nicotine and CO on fetal growth is thought to 
be a combination of both the effects on oxygenation by carboxyhaemoglobin and the 
vasoconstrictive effects of nicotine on the uterine, and potentially the umbilical, artery 
[230:279:280].
The potential effects of smoking during pregnancy on lung and airway developm ent may 
include structural alterations [69] and interference with the control of respiration [129:281], 
as well as the immune system [282]. One of the difficulties in assessing the adverse effect of 
in utero  exposure to cigarette smoke on the developing respiratory system is that, in many 
studies, the extent to which exposure to environmental tobacco smoke (ETS) after birth
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m ay have contributed is unclear, since measurements of infant respiratory function are 
often obtained some weeks following delivery. Several studies have reported the 
association between maternal smoking and reduced respiratory function in the neonatal 
period [40]; other studies have observed that the respiratory risk associated with parental 
smoking appears to be greatest in younger infants [14;283;284], providing further support 
that fetal developm ent may represent a critical time of pulmonary vulnerability.
Over the last 20 years, the prevalence of maternal smoking in pregnancy has declined, 
particularly in the non-manual social classes, and perinatal mortality rates have also fallen 
[13]. However, after evaluation of the relationship between different patterns of smoking 
habits and changes in causes of perinatal death, smoking during pregnancy continues to 
be strongly associated with fetal and infant morbidity and mortality [13;38;40;232;285].
1.5.6. Nutrition
Several investigators have suggested that lipids, especially essential fatty acids, are crucial 
for early lung development in the rat [286-289] and that lipid deficiency could delay  
differentiation of epithelial cells and impair surfactant production [290-292]. Increased lung 
distensibility in rats has been associated with a defective synthesis or conformation of 
connective tissue [293] and vitamin E has an antioxidant role by preventing lipid 
peroxidation [294-296]. Selenium deficiency leads to lung growth retardation with alveolar 
septal attenuation [297]. Recently, vitamin A has been highlighted as important in the 
control of elastin expression in the lung, and hence the process of air-space septation by 
which new alveoli are formed in the growing lung [298]. Other animal models have  
demonstrated that absolute lung volumes in rat pups from protein restricted dams are 
reduced, though specific lung volumes are elevated [299] and that neonatal protein 
deprivation results in decreased recoil pressure and lower elastin concentration [300]. 
Different adverse effects on the lung may be associated with variations in timing and  
severity of these insults [79]. These findings suggest that, in humans, malnutrition in late fetal 
life and infancy is likely to have an important effect on lung size [301] and hence  
respiratory function. In rats, severe food restriction can induce 'nutritional emphysema’ 
which, unlike true emphysema where there is destruction in the structural tissue of the lung, 
manifests by the presence of alveolar enlargement and septal attenuation [302]. This 
results in reduction in alveolar surface area, followed by subsequent emphysematous 
appearance [303]. Starvation has also been shown to aggravate elastase-induced injury. 
While refeeding appears to result in com plete recovery of the mechanical changes, there 
is only partial recovery of the morphometric changes induced by starvation [304].
53
Following delivery, the lung parenchyma continues to undergo structural and functional 
changes such as the formation and multiplication of alveoli, maturation of the capillary 
network and the accumulation of connective tissues. Thus, neonatal starvation may have 
adverse consequences on the rate of cell division and lung growth [305]. Lack of 
nutritional substrates during fetal and early neonatal life may impede cellular growth and  
differentiation, surfactant synthesis, inactivation of free radicals, connective tissue synthesis 
and post-injury repair [306]. Evidence from post-mortem studies of newborn infants who 
were underweight suggested that although alveolar development appeared appropriate 
for gestational age, their lungs were lighter than expected for body weight [307].
Inadequate maternal intake of vitamin E during pregnancy may influence the fetal 
immune system in such a way as to modulate the risk of childhood atopy [308]. Similarly, 
low level of vitamin E intake has been associated with atopic disease in children [309] and  
adults [310]. Other studies have suggested that inadequate postnatal nutrition may be  
associated with the development of bronchopulmonary dysplasia (BPD) [311:312]. In 
children with CF, nutritional status and growth are associated with changes in percent 
predicted forced expiratory volume in one second (FEVi), suggesting that nutritional 
intervention may enhance lung growth and optimise pulmonary function in children with 
CF [313].
1.5.7. Family history of asthma
It has been suggested that genetic factors may influence airway developm ent and  
function in early life [80]. There is good evidence for familial trends but until recently, the 
m ode of inheritance was unclear [314]. It is estimated that genes and the environment 
contribute approximately equally to the development of asthma [315]. Atopy is 
characterised by a genetic predisposition for generating IgE against common 
environmental allergens, expressed clinically as asthma, eczem a and rhino-conjunctivitis 
[315-317]. Several genetic studies indicate that multiple genes are involved in the 
pathogenesis of atopy and that different genes regulate the presence of increased levels 
of serum total IgE and specific IgE [317], which have been implicated in cross-sectional 
and longitudinal studies as one of the greatest risk factors for the development of asthma 
[47:315:318]. Cord blood IgE in newborn infants of atopic mothers is higher relative to those 
of non-atopic mothers, which is consistent with observations from genetic studies, 
reporting a higher risk of transmission of atopic disease from an affected mother than from 
an affected father [319-321]. Data from the Tucson longitudinal study suggested that 
children with maternal asthma were significantly more likely to have asthma if they had 
been exclusively breastfed (OR 8.7; 95% Cl: 3.4 to 22.2) [322]. Most, though not all 
[323:324], studies have suggested that preferential inheritance for asthma occurs through
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the maternal rather than paternal line [325:326]. Currently, intensive research using genetic 
and genomic methodology is underway to study polymorphisms in allergic disease, in 
order to identify the control or coding regions of genes that influence protein structure or 
expression and hence modify the presence and severity of disease [327-330].
Prospective data  from our laboratory showed that premorbid specific airway 
conductance (sGaw) and the time to peak tidal expiratory flow as a proportion of total 
expiratory time (tpTEFite), a measure of the degree to which expiratory flow and timing are 
modulated to slow lung emptying, were significantly diminished at 8 weeks and one year 
of ag e  am ong healthy term infants with a family history of asthma [37]. These infants were 
significantly more likely to develop wheezing at any given age during the first year of life 
than those without family history of asthma (proportional hazard ratio, 3.0, 95% Cl: 1.3 to 
7.3; p=0.013) (Figure 1.5) [37].
Figure 1.5. Proportion of infants remaining wheeze-free, according to family history of 
asthma, at any given age during the first year of life.
-  - 1CO
Dashed line: with first degree relative/s with asthma 
Solid line: no family history of asthma
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Adated from Dezateux et al [37].
In another study of wheezy infants, Sheik e t  a l reported that those with a family history of 
asthma (FHA) showed a significant increase in the ratio of forced flows at low lung 
volumes to peak flows following administration of a bronchodilator, whereas no such
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change was observed in those whose mothers smoked. However, healthy infants were not 
included as controls in this study [331].
An interim report from the Perth cohort study, based on measurements in 63 healthy 
fullterm infants measured betw een 2-10 weeks of life, suggested that bronchial 
responsiveness was increased in those with family history of asthma and those whose 
parents smoked [332]. However, the association between parental smoking and bronchial 
responsiveness was not confirmed when results from the entire cohort were analysed [333]. 
Findings from a London cohort study of 73 term infants with at least 1 atopic parent 
provided evidence that reduction in premorbid values of V ’maxFRc was associated with a 
history of maternal asthma, and at one year, analyses suggested that bronchial 
responsiveness assessed at ~1 month of age was significantly higher in infant girls who 
subsequently developed wheezy LRI com pared with asymptomatic girls, whereas there 
was no apparent difference in BR between infant boys who did or did not develop  
wheezy LRI during the first year of life [178].
At follow-up at six years of age (n=95), increased bronchial responsiveness a t 1 month in 
the Perth cohort was significantly associated with a reduction in F E V i and M E F25-75, and  
with an increased risk of lower respiratory symptoms and the em ergence of physician- 
diagnosed asthma by 6 year of age [333]. By 11 years of age, these children had 
significantly greater bronchial responsiveness and reduced M EF25-75, when com pared with 
other cohort members [6]. A link between neonatal bronchial responsiveness and lung 
function a t 11 years was attributed to the arginine16 (Arg16) allele of the (32 adrenoceptor
[334]. Results from follow-up assessment of the London cohort at age 10 years showed that 
early transient wheeze was associated with neonatal bronchial responsiveness but was not 
related to atopy or bronchial responsiveness a t 10 years [335]. However, neonatal 
bronchial responsiveness was significantly associated with reduced FEVi % at 10 years, and  
reduced neonatal V'maxFRc was found in those with the Arg16 or glutamine27 (Gin27) alleles
[335]. These findings suggest an increase in neonatal bronchial responsiveness and 
genotype-linked reduction in neonatal and later lung function among children born to at 
least one parent with a history of atopy or asthma.
1.5.8. Invasive prenatal procedures
Amniocentesis, or percutaneous transabdominal puncture of the uterus during pregnancy, 
to obtain amniotic fluid has been an established obstetric technique since 1973. It is 
commonly performed during pregnancy to obtain samples of amniotic fluid for fetal 
karyotype determination in order to diagnose abnormal fetal conditions or, at late 
gestation, to assay the concentration of sphyngomyelin and lecithin, the ratio of which
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provides an index for fetal lung maturity, prior to decisions regarding induction of labour or 
surgical delivery. This technique has been considered by many to be a safe procedure. 
However, evidence from animal studies suggested that amniocentesis adversely impacts 
on fetal lung development. Following amniocentesis, a decrease in breathing movements 
for up to 48 hours has been observed, possibly due to the resultant increase in uterine 
activity [336]. The inhibition of fetal breathing movements may adversely affect the control 
of fetal lung growth [337]. In addition, the withdrawal of amniotic fluid has been  
associated with suboptimal lung growth [338:339]. Morphometric studies of lungs of (term 
gestation) newborn monkeys, whose mothers had undergone amniocentesis, with and  
without fluid withdrawal a t mid and late gestations, showed that although the alveoli in 
experimental animals were of normal maturity, they were larger in size but fewer in 
number. Alveolar and alveolar duct diameters and respiratory bronchiolar length were 
reduced, and there was a reduction in gas exchange surface area [339]. These changes 
occurred regardless of the timing of amniocentesis, the amount of fluid removed and  
whether or not any fluid was removed after puncturing the amniotic membranes [339]. 
Similar observations were m ade by Moessinger e t  al, who reported that a single needle  
puncture of fetal rat membranes at late gestation resulted in persistent oligohydramnios, 
significant reduction in fetal weight and lung hypoplasia and hypotrophy [340].
In 1989, a method for diagnosis of fetal diseases by sampling the cells of the placental 
chorionic villi (CVS) for DNA analysis, presence of bacteria and concentration of 
metabolites was introduced. The effects of both the aforementioned invasive antenatal 
procedures on the incidence of neonatal respiratory problems and lung volume 
measurements have been investigated in newborn healthy, term, infants born to mothers 
who, during the first trimester of gestation, had undergone amniocentesis (n=74) or 
chorionic villi sampling (CVS; n=86) [341]. Six infants in the CVS group, but none in the 
amniocentesis group, required admission to the Special Care Baby Unit due to respiratory 
distress. Although there was no significant difference in the weight adjusted lung volume, 
9% of the overall values were below the 2.5th centile of the normal range [341]. In a further 
study by the same group of investigators, wherein 25 infants were included as controls, 
higher airway resistance (Raw) and lower specific airway conductance (sGaw) were  
observed in infants whose mothers had early amniocentesis (n=47) or CVS (n=19) [342]. The 
authors concluded that both amniocentesis and CVS in early gestation may adversely 
impair prenatal lung and airway growth and development [341:342].
1.5.9. Prenatal glucocorticoids
Adrenal glucocorticosteroids are commonly administered in low doses to women in 
premature labour to accelerate late-gestation fetal lung maturation, to prevent neonatal
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respiratory distress syndrome (RDS) and to improve perinatal survival of preterm infants 
[343-345]. However, research has suggested that high or repeated doses of 
glucocorticoids can inhibit somatic and lung growth [346:347]. Sex hormones appear to 
m oderate the effects of glucocorticoids so that fetal lungs mature more rapidly in females 
than in males [185]. In animal studies, while maturation of the surfactant producing type II 
pneumocytes is accelerated by the use of glucocorticoids [348:349], rapid alveolarisation 
(i.e., accelerated thinning of the alveolar wall thickness and an increase in aerated  
parenchyma) was observed rather than increased production of alveolar surfactant 
[350:351]. The use of betamethasone has been associated with increased collagen and  
decreased elastin concentrations [352], which may prevent normal alveolar development 
[91:346:353] and reduce the multiplication of bronchial smooth muscle cells [354]. Adverse 
effects of the use of multiple doses of prenatal corticosteroids have been reported, which 
include significantly reduced birth weight and head circumference [355] and persistent 
suppression of cortisol and epinephrine postnatally [356].
1.6. ASSESSMENT OF RESPIRATORY FUNCTION
There is a wide range of techniques now available for measuring lung volumes, respiratory 
mechanics, ventilation inhomogeneity and the control of breathing in infants [357]. In the 
following sections, an overview of fhese techniques, with particular emphasis on how they 
differ from adult lung function tests, will be presented together with a more detailed  
description of the use of forced expiratory manoeuvres during infancy. Parameters 
derived from the latter were used as the primary outcome variables for the various studies 
described in this thesis.
1.6.1. Application in adults and older children
Respiratory function tests (RFTs) are integral to the clinical assessment and m anagem ent of 
adults and older children with respiratory diseases. Their primary role is to identify the type 
and pattern of dysfunction presented by an individual and assess disease severity, which 
in turn helps to make or confirm a diagnosis, establish prognosis, or suggest and evaluate  
treatment. Respiratory function results are rarely diagnostic in their own right even among  
adults and therefore should always be interpreted in light of all other available 
information: for instance, clinical symptoms, chest x-ray or imaging and microbiology 
reports. Although isolated measurements of respiratory function may be useful, they are of 
limited value (if viewed as brief snapshots) com pared to serial measurements when 
changes in function may be evaluated, particularly with respect to growth or therapeutic 
interventions.
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Primarily, RFTs should be safe, simple and not unpleasant for the subject. A difficult 
procedure will have a high failure rate and may yield unreliable results, whereas one that is 
unpleasant will discourage participation both in the first instance and in any follow-up 
measurements. Acceptable tests should also be non-invasive and of short duration.
The result of a test should ideally be objective; in other words independent of the 
personality of the operator and motivation of the subject. It is important for the operator or 
observer to be aw are of the reproducibility or repeatability of different tests when 
interpreting clinical or physiological data . The repeatability of a test is usually assessed as 
the variation between measurements either on a single test occasion or between test 
sessions. The within-test repeatability is a function of the intrinsic variability of the 
procedure, after allowance has been m ade for the extent to which the results may 
improve with practice. The between-test repeatability represents the additional variability 
due to factors which operate on the subject, operator or equipment over a longer period. 
Some of this variability can be eliminated by careful calibration of the equipment, 
standardisation of measurement conditions by controlling for ambient room temperature, 
posture, the time of day and interval since any meals or medication. Nevertheless, 
considerable within-subject and between-occasion variability may persist, particularly 
amongst those with respiratory disease, which may reduce sensitivity to detect significant 
changes within individuals in response to any intervention [358].
1.6.1.1. ‘Ideal test’: characteristics
In addition to being acceptab le  to the subject (and where applicable, to their parents), 
an ideal respiratory function test would be one that is -
• applicable to individuals of any ag e  and arousal state;
• independent of subject co-operation;
• safe and easy for both the subject and operator to perform;
• reproducible both within and between subjects and between test occasions;
• sensitive enough to detect small changes with growth and distinguish clearly 
between health and disease;
• provide accurate and specific information about the structure and function of the 
lungs to clarify mechanisms underlying clinical status or disease, and to aid 
treatment m anagem ent.
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At present, no such test exists and even if it did, no single test is ever likely to provide all the 
necessary information for either a clinical or research study. Nevertheless, there is 
widespread use of RFTs amongst adults and older children as summarised in Table 1.4. By 
contrast, despite the high morbidity of respiratory disease in the first few years of life 
(section 1.2.1), the role of respiratory function testing in clinical m anagem ent remains 
controversial in this age group [359:360] as discussed below.
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Table 1.4. Some applications of respiratory function tests in adults
Field of application Subdivision Reason for testing
Clinical science Diagnosis Causes of wheeze, breathlessness, cyanosis and aspects of respiratory failure
Clinical assessment Disease of the lung, chest wall, heart and circulation, and central nervous system 
Serial assessment of disease state and/or function
Medical treatment Oxygen therapy, bronchodilator therapy, assisted ventilation
Surgical treatment Suitability for operation
Anaesthetics Suitability for and management during and after anaesthesia
Research application Evaluation of treatment (including surgical procedures) and new therapy 
Assessment of progress
Relationship of deranged function to abnormal structure
Human biology & physiology Physiology Normal function; changes with posture, exercise, pregnancy, measurement conditions, growth 
and development
Physiological determinants Relation to age, sex, size, ethnic groups, activity
variation due to time of day, season, climate, geographical location
Public health science Epidemiology Effects of smoking and air pollution
Prevalence of respiratory impairment; prognosis (e.g., FEVi as predictor of all causes of mortality) 
Identification of high-risk cases
Rehabilitation Capability for physical work
Occupational medicine Health in industry Pre-employment, periodic and exit examinations, effects of respiratory hazards, suitability for 
strenuous work
Establishment for safe conditions
Diagnosis & assessment of 
occupational lung diseases
Asbestosis, farmer's lung, beryllium disease, pneumoconiosis of coal-workers and other 
occupational groups
Lung disease in grain handlers, hard-metal workers, silo fillers, exposure to proteolytic enzymes, etc
Medicine and law Assessment of disability Function of the lungs and the capacity for exercise
Adapted from Cotes [358],
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1.6.2. Measurement conditions: adults versus infants
As discussed in section 1.4, m arked deve lopm en ta l changes in respiratory physiology 
o ccu r during the first years of life and  im p a c t on both the measurements and  
in terpreta tion  of results. The im portan t d ifferences in undertaking RFTs in infants and  young 
children < tw o  years of age  re late to the need for miniaturised equ ipm ent, e th ica l issues, 
posture, sleep state, sedation and  the fa c t tha t these subjects canno t be asked to 
undertake  any specific breath ing m anoeuvres and  tend to be preferential nose breathers 
[121:357], Furthermore, techniques used to  assess respiratory function in this a ge  group 
have  ten d ed  to  be highly com plex, requiring the operators to undergo intensive training, 
a nd  have  been expensive, hence  lim ited to  specialist laboratories.
In contrast to  the upright, seated position a d o p te d  by adults and  older children, the 
standard  position for infant RFTs is usually supine, w ith the head in m idline position, the 
neck and  shoulders supported in slight extension to ensure p a te ncy  of the airways, w ith 
measurements recorded in consecutive periods of relaxed, quiet sleep, w hen breath ing  
patterns are regular [361], The main differences in measurem ent conditions be tw een  
adults and  infants are summarised in Table 1.5.
Table 1.5. Comparison of differences in measurement conditions in adults and infants
Conditions Adults Infants
Position Upright Supine
Sleep state Awake Asleep
Sedation Not required Frequently used
Test duration 20-40 minutes > 2 hours
Apparatus M outh p iece  & nose c lip Face mask
Unless clin ica lly ind ica ted , sedation is genera lly con tra -ind ica ted  for RFTs in new born 
infants. A lthough successful measurements in a full range of fests can  be ach ieved  in post­
prand ia l natural sleep in infants in the first m onth of postnata l age  (co rrected  for 
prem aturity), it becom es increasingly d ifticu lt to perform any of the m ore com p lex 
measurements, such as p le thysm ography and  forced  expiratory manoeuvres, w ithou t 
some form of sedation. The dosage and  use of sedation are d ep e nd e n t upon the age  
and  cond ition  of the infants, the reason for the test and the type of test being perform ed.
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The most com m only used sedative agents are chloral hydrate and  its derivative, triclotos 
sodium. Further details are presented in C hapte r 2 (section 2.4.8). As infants are 
preferentia l nasal breathers (section 1.4.4), the presence of any upper a irw ay respiratory 
symptoms will w arrant cance lla tion  and  defe rm ent of the test for a t least 3 weeks, since 
nasal resistance and  re la ted  param eters can  change  significantly due to mucosal swelling 
and  excessive secretions.
In order to in terpret tests of in fant respiratory function, it is necessary to assess the valid ity of 
measurements, be  know ledgeab le  regarding w ha t constitutes a physiological or clin ica lly 
significant ch an g e  within or be tw een  infants and  com pare  the results e ither w ith a 
specially se lected contro l group or w ith a re ference popu la tion  [47;362]. However, the 
need  for sedation in infant testing, toge the r w ith the time-consuming nature of the tests, 
seriously limits the possibility of assessing short-term variability or repea tab ility  of 
measurements (since it is not advisable to repea t dosage of sedation within re latively short 
intervals [363]), as well as a ttributing to a pauc ity  of suitable reference values.
If reproducib le  measures of lung volum e or respiratory m echanics are to  be ob ta ined , it is 
essential tha t a representative and  stable end-expiratory level is established before 
com m encing  d a ta  co llection. To ach ieve  this, it is necessary to w a it for the in fan t to  be in 
behavioura l quiet, non-rapid eye m ovem ent (non-REM) sleep and  to ensure tha t d a ta  are 
co lle c ted  during consecutive periods of this sleep phase. Consequently, each  test session 
is re latively pro longed and  lasts for approx im ate ly  tw o hours or more. The need for 
sedation for respiratory function testing is a m ajor contributory fac to r c ited  by parents 
(particularly of healthy infants) when declin ing  to  pa rtic ipa te  in such studies. Nevertheless, 
most popu la tion  based studies ach ieve  pa rtic ipa tion  rates of a bou t 25% [37; 186; 187:332].
1.7. RESPIRATORY FUNCTION TESTS IN INFANTS AND YOUNG CHILDREN: 
AN OVERVIEW
1.7.1. Introduction
Attem pts to measure adu lt respiratory function  d a te  from the 1700s when Humphrey Davy 
m ade  the first lung volum e measurements. The w a te r spirometer was in troduced  for use in 
adults in 1846 [364], However, it was not until the 1890s tha t the first a ttem pts to  measure 
tida l ventilation in infants were m ade  by Eckerlein [365] and  Dohm [366] using a small 
spirometer a tta ch e d  to a facem ask. Their equ ipm ent had excessive d ea d  space  and  
reasonable a ccu racy  was not ob ta ined  until the in troduction of the head-ou t 
plethysm ograph by Murphy and  Thorpe in 1931 [367]. This a llow ed tidal ventilation to  be  
determ ined w ithout any appara tus d ea d  space. In 1949, Cross refined this appara tus by
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in troducing a neck seal and reported  tida l breath ing param eters for term infants [368]. An 
early p lethysm ograph incorpora ting  a w a te r spirometer was in troduced in 1950 [369]. A 
brief description of the main techniques used to  assess lung function are presented below , 
w ith a more de ta iled  a cco u n t of fo rced  expiratory manoeuvres in sections 1.9 and  1.10.
1.7.2. Measurements in infants and young children
The focus on the assessment of a irw ay function during early life, using techniques to 
measure a irw ay or respiratory resistance and  forced  expiratory param eters, reflects the 
fa c t tha t wheezing illnesses of e ither a transient or persistent nature a ccou n t for m ajority of 
the respiratory disorders encounte red  in infants and young children beyond the neonata l 
period. More recently, it has been emphasised tha t measurements ob ta ined  from forced  
expiratory manoeuvres are determ ined not only by the calibre of the airways but also by 
a irw ay wall com p liance  and elastic recoil of the surrounding parenchym a [370].
The lack of standardised equ ipm ent and  techniques for testing infants in the past, 
toge the r w ith the need for sedation, has resulted in a de fic iency of norm ative d a ta , w hich 
limits the ob jective  assessment of m any respiratory disorders in infancy. In particular, the 
lack of standardisation hampers co lla tion  of d a ta  from various centres, since custom - 
m ade  equ ipm ent and  d ifferent m ethods have been used to co llec t da ta . This has resulted 
in pub lica tion  of relatively small ind ividual d a ta  sets from which reference equations have 
been deve loped ; consequently such equations are frequently not generalisable to 
populations outside the centres tha t d eve loped  them. In recent years, rap id  techn ica l 
advances and  co llabora tive  efforts by the European Respiratory Society and  Am erican 
Thoracic Society (ERS/ATS) in ternational task force have begun to address this problem  
[371-378], and  future m ulti-centre trials and  co lla tion  of d a ta  should be greatly fac ilita te d  
by the standardisation of equ ipm ent and  protocols.
1.7.2.1. Oesophageal manometry
As a result of ingenious m odifications of in fan t naso-gastric feed ing tubes, oesophagea l 
m anom etry was used to assess dynam ic pulm onary m echanics (i.e., com p liance  and  
resistance) in m any of the earlier studies in spontaneously breath ing infants. When using 
this techn ique , changes in airflow and  volum e a t the airway opening are re la ted  to 
simultaneous changes in oesophagea l pressure, w hich re flect changes in pleural pressure 
(hence the transpulmonary pressure) due to the close apposition of the fla cc id  
oesophagus to the pleural space [379].
The c o n c e p t of m echan ica l analysis of the respiratory system is based on d a ta  from a 
series of studies published by Rohrer in 19 15 in w hich he established the fundam enta l
64
relationship be tw een  pleural pressure, lung elastic recoil pressure and a lveo lar pressure 
[380]. However, it was not until the 1950s, follow ing the in troduction of e lectrica l record ing 
appara tus  [369] and  the a c c e p ta n c e  of oesophagea l pressure as an ind irect measure of 
pleural pressure, tha t oesophagea l m anom etry beca m e  an established techn ique  and  a 
significant num ber of measurements was recorded . The first oesophagea l balloon was 
described in 1952 [381]. During the 1950s and  early 1960s, a series of articles described 
im proved techniques including the deve lopm en t of the "occlusion test" and  the 
app ro p ria te  characteristics for oesophagea l balloons when used in adults [382-385]. The 
occlusion test is used to dem onstra te  tha t changes in oesophageal pressure accu ra te ly  
re flec t those of pleural pressure. Im provem ents in the use of oesophagea l balloons for 
m easurem ents in infants were described by Beardsmore et al in 1980 [386].
In add ition  to oesophagea l balloon catheters, both  liquid filled catheters [387;388] and  
flexible catheters m ounted with miniaturised transducers a t the tip  [389-391] have also 
been used to measure oesophagea l pressure in adults and infants. However, their use in 
infants beyond the neonata l period, w hich m any parents view as relatively invasive, has 
been largely superseded by the in troduction  o f the occlusion techniques to  assess passive 
respiratory m echanics (section 1.7.2.5).
1.7.2.2. Static lung volumes
The first measurements of lung volumes in infants were published in the la te  1950s [392;393] 
and  used helium dilution w hich had  first been described for use in adults by Willmon and  
Behnke in 1948 [394], The early helium dilution techn ique was only suitable for 
spontaneously breath ing  infants. By 1970, measurements in sick infants b e ca m e  feasible 
w hen Krauss and  Auld in troduced a system incorpora ting  a re-breath ing b ag  [395].
A lthough the nitrogen (N2) washout techn ique  was described for use in adults by Darling 
e t al in 1940 [396], its use in infants was not reported  until 1962 [397], w ith a further report by 
Ronchetti et al in 1975 [398]. In 1985, this techn ique  was simplified by the deve lopm en t of 
m ethods using open, rather than closed, circu it [399], and further a d a p te d  for use in 
ven tila ted  infants by Sivan et al in 1990 [400].
At the same tim e as the helium dilution m ethod  was being deve loped  for use in infants, 
w ho le  body  p lethysm ography was being d eve loped  to measure FRC and Raw in adults by 
DuBois et al [40l;402]. By I960, this m ethod  had  been a d a p te d  for measuring lung volum e 
in infants [403] and  tor the assessment of Raw the follow ing year by Polgar [404]. With further 
m odifications, including the add ition  of a hea ted  re-breathing circuit in the 1970s 
[405:406], the whole body plethysm ograph b eca m e  established as a standard m ethod  for 
measuring FRC and Raw in infants [407]. A irway function m ay also be expressed as
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c o n d u c ta n c e  (the rec ip roca l ot resistance) or specific co nd u c ta n ce  by relating 
c o n d u c ta n c e  to lung volume.
A po ten tia l a d va n ta g e  of the p le thysm ograph ic techn ique is tha t both FRC and  Raw can 
be co m p u te d  from the p le thysm ographic d a ta  recorded during quiet tidal breath ing, 
p rov ided  tha t BTPS (body tem perature, pressure and  saturated) conditions are ach ieved . 
However, the com plexity  of m ain ta in ing  respired gas a t BTPS cond ition  using a re­
b reath ing  bag , and  the re la ted  concern  regarding infection control, remain a major 
obstacle . Besides being bulky and  expensive, extensive training is essential in order to 
ob ta in  techn ica lly  satisfactory and  a ccu ra te  plethysm ographic recordings, thus restricting 
the ava ilab ility  of this test to specialised centres. It should be noted tha t p le thysm ographic 
lung volum e (FRCpieth) includes the volum e of gas trapped  behind closed airways which 
d o  not con tribu te  to tidal ventilation [407;408j. In health, similar FRC measurements should 
be  o b ta ined  using the p lethysm ographic and  gas dilution techniques within the same 
subject on one test occasion. However, in the presence of a irway disease, estimates of 
FRC assessed by these different techniques are not in terchangeable , since gas dilution 
techniques only measure the volum e of tho rac ic  gas tha t com m unicates be tw een  the 
alveoli and airway opening. Thus, in the absence  of any techn ica l problems, the presence 
of gas trapp ing m ay be inferred by the d iffe rence  betw een the tw o FRC measurements.
The m ultip le -breath  inert gas washout (MBW) techn ique  was first in troduced in the 1950s 
for measuring FRC (FRCmbw) and  for assessing overall ventilation inhom ogeneity. The 
orig inal test was the N2 MBW test using 100% oxygen (O2) for the washout [409]. More 
recently, this techn ique  has been reappra ised and  m odified for use specifically in 
spontaneously breath ing  infants and  young children. Measurements require a wash-in 
phase during w h ich  the individual breathes a dry gas mixture conta in ing  one or m ore inert 
tracer gases of d ifferent m olar mass (for exam ple, the use of both 4% sulphur hexafluoride 
[SF6] and  4% helium [Hej in 21% O 2 and  b a lan ce  N2) until equilibration of the concen tra tion  
of the principal tracer gas is reached  throughout the lungs. For the washout phase, the 
special gas mixture is d isconnected  during expiration and  the individual breathes room air 
until the end-tida l tracer gas concen tra tion  is be low  '/4 0 th of the starting concen tra tion  
[410;411]. The gas concen tra tion  is m easured a t the m outh using an app rop ria te  gas 
analyser while airflow is measured simultaneously by a pneum otachom ete r or similar flow  
sensor. In add ition  to the FRC measurem ent, several indices of ventilation inhom ogene ity  
m ay be ca lcu la te d , the main param eters being the lung c lea rance  index (LCI), mixing 
ra tio  (MR) and  m om ent ratio [411-414], In genera l, e levated  values of these indices are 
ind ications tha t ventilation distribution, as a measure of small a irway function, is im pa ired  
[411;414],
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1.7.2.3. Tidal breathing parameters
Abnormalities of tidal expiratory flow  patte rn  were observed in the 1940’s in adults w ith 
respiratory diseases [415-417] and  were first reported in children with asthm a and  cystic 
fibrosis (CF) in 1949 by Kaye et al [418] w ho suggested tha t tidal flow recordings cou ld  be 
clin ica lly useful. However, it was not until 1981 tha t Morris and Lane proposed the de ta iled  
analysis of tidal expiratory tlow patte rn  as a quan tita tive  m ethod for assessing lower airway 
function  based on measurements in adults [419]. Subsequently, many studies in infants and  
young children reported  de ta iled  analysis of various tim ed indices during tidal breath ing, 
in particu la r the ratio  of time to peak tida l expiratory flow (tptef )  to to ta l expiratory time (tE) 
w h ich  ind irectly reflects a irway ca lib re  a n d /o r control of breath ing due to  underlying 
respiratory m echanics. Infants w ith bronchopu lm onary dysplasia [420] and those exposed 
to  m aterna l smoking during p regnancy [421 ;422] have been reported to reach tidal peak 
expiratory flow more rapidly than a ge -m a tch ed  controls. The tidal expiratory ratio (tp t e f : ts) 
has also been observed to be lower in m ale infants w ho subsequently deve loped  
wheezing illnesses [186:423].
Since it is a relatively simple p rocedure  to  record tidal breath ing patterns in neonates and  
infants, this m ethod of assessing a irway function can  potentia lly  be app lied  to  large 
ep idem io log ica l studies, w ithout the need for sedation. This led to a surge of interest in the 
analysis of tidal b reath ing indices. However, due to rapidly chang ing  breath ing patte rn  
and  considerable intra- and  inter-subject variability in tidal indices, particularly during early 
life, d a ta  must be co llec ted  during qu ie t sleep w ith analyses ca lcu la te d  on a large 
num ber of breaths [424]. Despite m any reports, the relationship be tw een the tim ing indices 
and  respiratory m echanics remains unclear.
1.7.2.4. Body surface measurements
All the methods described above  require a ccu ra te  measurement of flow and  volum e 
changes a t the a irway opening by using a PNT or similar flow sensor. However, the use of a 
flow measuring dev ice  usually requires a tight-fitting face  mask; the app lica tion  of such 
equ ipm ent m ay itself a ffe c t ventilation due to the increased load and  trigem inal 
stimulation [425:426] and necessitate considerable  techn ica l skill. Consequently, numerous 
efforts have been em ployed to deve lop  less invasive methods of measuring tida l volum e 
a nd  respiratory tim ing. Several m ethods have been assessed for use in both  spontaneously 
b reath ing  and  m echan ica lly  ventila ted  infants, including im pedance  pneum ography, 
m agnetom eters, strain gauges and  respiratory induc tance  plethysm ography (RIP) [427- 
432], of w hich RIP has been used to assess a irway obstruction and overall e ffic iency of the 
respiratory pum p (chest wall and respiratory muscles) by analysis of qua lita tive  d a ta  of 
tho raco-abdom ina l motions [430:433]. D ifferent m ethods of ca libra tion for RIP have been
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described  [434;435] including a u to m a te d  qua lita tive  selt ca lib ra tion  during tida l b reath ing  
(QDC) [436:437].
A lthough surface m easurem ent has g rea t po ten tia l for being a simple and  non-invasive 
test, it has proved  som ew hat d isappo in ting  and  failed to ach ieve  w idespread use in 
infants. This is mainly due to the d ifficu lty in achieving optim al ca lib ra tion  in infants, 
particu larly those born preterm , because of their highly com p lian t chest wall w h ich  
frequently  moves asynchronously w ith the abdom en  [157:438]. Nevertheless, non-invasive 
RIP has recently  been  used in an anim al m odel to  dem onstrate the feasibility of estim ating 
lung vo lum e recru itm ent in response to  a range of positive pressures delivered a t the 
a irw ay open ing  during high frequency oscillatory ventilation [439]. Tidal ventilation profiles, 
o b ta in e d  using RIP in a group of preterm  infants receiving nasal continuous positive a irway 
pressure support, have been characterised by a pow er law functiona l flow spectrum  [440], 
Ventila tory responses to hypoxia and  hypercapnia , in 3-month old term infants w ith 
period ic breath ing or obstructive apnoea , have also been investigated using RIP [441 ].
1.7.2.5. Passive respiratory mechanics
The relative com plexity and  invasiveness of whole body p le thysm ography and  
oesophagea l m anom etry led to efforts in the 1980s to deve lop  simpler tests specifically for 
infants, nam ely the airway occlusion techniques [442] and the rapid tho raco -abdom ina l 
compression (RTC) techn ique  [443]. These m ethods perm itted  the assessment of the 
m echan ica l properties of the respiratory system, by measurements of fo ta l respiratory 
com p liance  and  resistance, and  assessment o f peripheral a irway function, respectively. 
An outline o f m ethods for assessing passive respiratory m echanics is presented below , 
while the RTC techn ique  is discussed in de ta il in section l .9.
In 1954, Com roe et al first described measurements of respiratory m echanics during 
passive expiration in adults and  in anaesthetised cats [444]. Such measurements w ere 
lim ited to  paralysed or highly tra ined subjects because of the need for muscle re laxation 
[445:446]. In 1976, Olinsky et al reported  the first measurements of passive m echan ics in 
unsedated infants, by m aking use of the apnoe ic  pause, w ith respiratory muscle 
re laxation, induced  in infants by stimulating the vaga lly  m ed ia ted  Hering-Breuer inflation 
reflex [447] (section l . 4.2.2). They d eve loped  the multiple occlusion techn ique  (MOT) in 
w h ich  a series of brief occlusions a t the a irw ay opening were m ade during inspiration, 
thereby a llow ing a pressure-volume p lo t for the respiratory system to be crea ted , w ith the 
slope representing static com p liance .
In 1982, M ortola et al described the m easurem ent of the respiratory tim e constant (trs) 
from passive expirations follow ing release of a brief a irway occlusion a t end-inspiration,
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and  ca lcu la te d  respiratory resistance (Rrs) using this time constant and  co m p lia nce  (Crs), 
as assessed from the MOT (since irs = Crs x Rrs) [448]. In the same year the single breath 
techn ique  (SBT), in w hich Crs and  Rrs w ere measured from the same breath  in 
anaesthetised cats, was described [449]. Subsequently, Le Souef et al [450] and  Thomson 
et al [451] reported  the use of the SBT in spontaneously breath ing and  m echan ica lly  
ven tila ted  neonates, respectively.
The a d v a n ta g e  of the a irw ay occlusion techniques is tha t d a ta  co llection  is relatively easy, 
requiring simple and  com para tive ly  inexpensive apparatus, which can  be set up on a 
po rtab le  trolley a llow ing cot-side measurements. The occlusion techniques are also well 
to le ra ted  by young infants in natural qu ie t sleep. However, it relies on the assumptions 
tha t:
• pressure equilibrates rapidly throughout the airways during a irway occlusion, so 
tha t the recorded pressure p la teau  a t the airway opening reflects the elastic recoil 
pressure of fhe respiratory system a t any given volume above  the end-exp ira tory 
level [442:452]
• on release of the occlusion, there is com p le te  relaxation of the respiratory muscles 
such tha t expiration is passive
• the respiratory system can  be described by a single time constant throughout 
expiration [450].
These assumptions m ay not always be valid, particularly in infants w ith respiratory disease 
w ho  have e leva ted  resistance and  respiratory rates, wherein pressure equilibration is 
de layed , and  inhom ogeneous ventila tion results in de layed  lung em ptying from some 
areas of the lung.
1.7.2.6. Forced oscillation technique (FOT)
The fo rced  (or impulse) oscillation techn ique  is ano ther m ethod of assessing dynam ic  
respiratory m echanics. By app ly ing  a sinusoidal pressure w aveform  (term ed a ‘fo rc in g ’ 
function) to the respiratory system via the tracheo-bronch ia l tree or thorax, and  measuring 
the resulting flow a t the airway open ing, the respiratory im pedance  (Zrs), w hich reflects 
both  the resistive and  elastic properties of the respiratory system, can  be determ ined. 
A lthough the techn ique  was first in troduced  by DuBois et al in 1956 [453], it has been used 
relatively little. Since a re-appraisal in the la te  1980s, this techn ique has been a pp lied  to 
both  ventila ted  and  spontaneously breath ing subjects of d ifferent ages.
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Potentially, this techn ique  is ideal for use in infants and young children, since it imposes 
pressure oscillations (non-invasively) on the sub ject’s spontaneous breath ing, does not 
disturb the airways and  requires no ac tive  co -opera tion  [454-460]. However, this m ethod  
assumes tha t both  the measuring system and  the m echan ica l properties of the respiratory 
system are linear during the tim e of m easurem ent and remain so for the am p litude  of 
pressures app lied  in order for respiratory resistance and reac ta n ce  to be  ca lcu la te d  for 
e a ch  frequency con ta ined  in the forc ing function. The pressure oscillations m ay be 
a p p lie d  a t a single or multip le d iffering range of frequencies. The m echan ica l properties of 
the respiratory system vary depend ing  on the range of frequencies used. In adults, 
frequencies be tw een  2-32 Hz are generally used [461]. The lower frequencies (1-2 Hz) 
primarily re flect the behaviour of the parenchym a while the higher frequencies (>5-10 Hz) 
re flec t the m echan ica l properties of the conduc ting  airways [370:462]. At very high 
frequencies (>100 Hz), respiratory im p e da n ce  will conta in  inform ation on a irway wall 
m echan ics [463:464]. Currently, the optim a l range of frequencies for use in infants is 
unclear. Com plex m athem atica l models are also required for d a ta  analysis.
1.7.3. Application of RFTs in infants
Despite the difficulties associated w ith in fant respiratory function testing (section l . 6.2), 
recen t years have witnessed considerable  advances in this field and  w idespread 
a pp lica tion  of these tests, as summarised in Figure l .6. Although infant RFTs are potentia lly  
useful in a id ing diagnosis and  contribu ting  to  the evaluation of trea tm en t strategies, their 
m ain a pp lica tion  has been in research, in both  clin ica l and popu la tion  based studies 
(Figure l . 6). The more controversial a rea in w h ich  RFTs are being used has been in the 
c lin ica l m anagem ent of individual sick infants [359:360].
Recent intensive in ternational co llabo ra tive  efforts, involving physiologists, scientists, 
clin icians and  m anufacturers, have fac ilita te d  consensus on standardisation of 
equ ipm ent, software for d a ta  co llec tion  and  quality contro l issues regarding d a ta  
analyses, and  have cu lm ina ted  in a series of publications [371-374:376:378:409:465]. These 
endeavours should im prove the feasibility of app ly ing  RFTs in clin ica l settings and  perm it 
m ulti-centre  co llabora tive  studies to  deve lop  m ore robust norm ative d a ta  [359:377],
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Figure 1.6. Applications of respiratory function testing in infants.
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1.8. FORCED EXPIRATORY MANOEUVRES
1.8.1. Introduction
Despite the w ide  range of RFTs now ava ilab le  for use in infants, the most com m only used 
app ro a ch  remains assessment of a irway function using either the partial or 'full' fo rced  
expiratory (FE) manoeuvres, which are the focus of this thesis. Detailed description of 
equ ipm ent and m ethodo logy used in con junction  with these techniques is presented in 
C hapte r 2, w ith a discussion of re levant background  theory and a literature review of their 
app lica tions during in fancy being presented in sections l .9 and l .10, respectively.
Measurements of vital ca p a c ity  were originally m ade by Hutchinson in 1846 [364], 
However, these measurements did not fully eva luate  ventilatory function. In 1933, 
Hermannsen in troduced the maximum breath ing ca p a c ity  (MBC) test [466] w hich 
becam e  w idely used after Baldwin et al published normal standards in 1948 [467], MBC 
measurements are used to assess dynam ic changes in lung volume and are considered
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useful in eva luating  overall ventilatory function. During the late 1940s and early 1950s, it 
b e ca m e  feasible to quantify respiratory disability in conditions such as asthm a and  
em physem a by record ing rate of exhaled air during a forced expiration [468:469]. This 
m ethod, known as the fo rced  expiratory m anoeuvre, requires the subject to inspire 
m axim ally to to ta l lung c a p a c ity  (TLC) and  then im m ediate ly exhale as rapidly, 
com p le te ly  and  as forcib ly as possible to residual volume (RV).
K now ledge of the natural history and  prognosis of diseases associated w ith airway 
obstruction in o lder subjects has mostly been derived using variables ob ta ined  from forced  
expiration. The FE m anoeuvre is w idely used, in part because it is relatively easy to perform 
and  the flow-volum e curves thus ob ta ined  tend to be highly reproducib le  and  relatively 
easy to  analyse. A robust and w idely used index from spirometric measurements is the 
fo rced  expiratory volume in one second (FEVi), which is considered a reflection of centra l 
a irw ay function. When expressed as a pe rcen tage  of the forced vital c a p a c ity  (FVC), 
FEVi/FVC is a measure of overall a irway obstruction. Maximal mid- or end-expira tory flows 
from the e ffo rt-independent portion of the flow-volum e curve are considered more 
sensitive to obstruction towards the lung periphery [470:471], These measurements are 
useful because, provided reasonable effort is m ade, expiratory flow is independen t of fhe 
force driving flow over most of the expired vital ca pa c ity . By com paring  fo rced  flows and  
volumes, it is feasible to dem onstra te  tha t lung em ptying is slower in individuals w ith a irway 
obstruction re lative to healthy subjects. However, changes in peripheral a irway obstruction 
or resistance ca nn o t be d e te c te d  by spirometric measurements until the disease has 
progressed significantly. The theore tica l background  to these measurements is described 
in the follow ing section.
1.8.2. Theoretical background
In adults and  older children, expiratory flow-lim itation is the underlying princip le tha t allows 
sensitive and  useful spirometric assessment of a irway function to be m ade. FE m anoeuvres 
are either perform ed from TLC, known as maximal forced  expiratory manoeuvres, or from 
some lower volume, term ed partia l fo rced  expiratory manoeuvres.
Figure l . 7 illustrates a classical m axim al fo rced  expiratory flow-volum e (MEFV) curve 
derived from an adu lt exhaling as hard as possible to residual volume (RV), follow ing an 
inspiration from FRC to TLC. The com m only  reported  indices from a MEFV curve include:
• m easurem ent of the tota l volum e expired (FVC),
• volum e expired a t a set tim e interval (FEVt), most com m only taken a t one second 
a fte r onset of forced expiration (FEVi),
72
• peak expiratory flow (PEF), and
• maximal expiratory flow measured a t various proportions of FVC (MEF%): for 
exam ple, maximal expiratory flow a t 50% or 25% of FVC rem aining in the lungs, 
which is abb rev ia ted  to M E F 50 or M E F 2 5 , respectively. When using the Am erican 
notation, the la tter are referred to FEF50 and FEF7 5 , reflecting forced  expiratory flows 
when 50% and 75% of FVC has been exhaled.
These param eters are usually highly reproducib le  in older subjects.
Figure 1.7. A typical MEFV curve obtained from an adult.
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Such d a ta  are ob ta ined  during a fo rced  expiratory m anoeuvre to RV, 
fo llow ing a prior maximal inspiration from FRC to TLC.
Although maximum expiratory flow has been shown to be highly dep e nd e n t on changes 
in in tra thorac ic  a irway size, fo rced  expiration is also determ ined by the elastic resistance 
or recoil of the lung and tho rac ic  ca g e  and  by airway compression or closure [ 4 7 2 -4 7 5 ] .  
Thus, m axim al flow will be reduced if there is loss of elastic recoil of the lung or an increase 
in a irw ay com p liance . Since assessments of fo rced  expiration are likely to re flect the net 
e ffe c t of a ltered m echan ica l properties of the lung (for exam ple, reduced  a irw ay size 
a n d /o r lung elastic recoil), they could  provide a bette r measure of the overall dysfunction 
in individuals with airway obstruction, co m p ared  with assessment of Raw on its own [47 6 ] .
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During fo rced  expiration, expiratory flow is independen t of the driving pressure over most 
of the expired vital ca p a c ity , once  a threshold value of driving pressure is exceeded . This 
phenom enon  is known as expiratory flow-lim itation. While FVC provides an ind ica tion  of 
the lung volum e and  FEVt reflects centra l a irway function, once  flow-lim itation is ach ieved , 
measurements of MEF% would no longer be  defined  by respiratory effort but are exclusively 
d e p e n d e n t on the resistance of the in tra thorac ic  airways, and accord ing  to earlier 
publications, should therefore represent the ca libre  of the airways through w h ich  air is 
expe lled  [473-475:477], In the past, it has been w idely a c c e p te d  tha t minor degrees of 
a irw ay obstruction m ay be re flec ted  by diminished flows a t lower lung volumes, hence  
flow measurements such as MEF25 have been taken to ind ica te  peripheral a irw ay function. 
This c o n c e p t has, however, been cha llenged  more recently by suggestions tha t in 
add ition  to a irw ay resistance, flow-lim itation is also d ependen t on airway wall com p lia nce  
during a fo rced  expiratory m anoeuvre, such tha t the MEFV curve represents the 
‘ in teg ra ted  o u tp u t’ of the entire respiratory system. As such, it m ay not be easily 
partitioned  into com ponents to re flect d ifferent ana tom ica l regions [476].
An understanding of the underlying physiology of forced expiration is necessary to enab le  
co rrec t app lica tio n  of the techn ique  and  valid in terpretation of results. During the test 
p rocedure , in add ition  to inspiring to TLC, the subject must em ploy a d e q u a te  expiratory 
e ffort to  ach ieve  flow -lim itation, and  such effort must be m ain ta ined long enough to  
em p ty  the lungs to residual volum e [478]. These manoeuvres are generally easy for adults 
and  o lder children but more d ifficu lt for children < 5-6 years, and impossible w ithout 
assistance for infants.
1.8.2.1. Flow-limitation
The m echanism  for expiratory flow-lim itation is com plex. The princip le govern ing the basic 
m echanism  of this phenom enon has been recognised as a com bina tion  be tw een  a irway 
compression and  the pressure d rop tha t occurs downstream  along the airways, from the 
alveoli to the a irw ay open ing [472:475:479].
In 1958, FHyatt et al c re a te d  a series of iso-volume pressure-flow curves by p lo tting  
in tra tho rac ic  pressures (measured using an oesophagea l catheter) as a function  of 
expiratory flows measured a t the m outh a t specific lung volumes for each  maximal 
expirafion and  inspiration [477]. These iso-volume pressure-flow curves dem onstra ted tha t 
expiratory flow b eca m e  lim ited, or e ffo rt-independent, a t relatively m odest positive 
in tra tho rac ic  pressures, as illustrated in Figure 1.8. It can be seen from this Figure tha t a t 
high lung volumes, the expiratory flow continues to increase correspondingly w ith 
increasing effort (accom pan ied  by rising intrapleural pressure). Ftowever, a t mid or low
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lung volumes, flows reach a p la teau  a fte r a certa in minimal or critica l effort, and  no 
increm ent in expiratory flow is ach ieved  w ith further increase in intrapleural pressure. Under 
these conditions, flow is said to be lim ited or e ffo rt-independent.
Figure 1.8. Isovolume pressure-flow curves.
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These curves were p lo tted  for three lung volumes, each  of w hich was derived from a series of 
fo rce d  expirations and  inspirations. (Figure a d a p te d  from West [ l 03])
The c o n c e p t of flow -lim itation is w idely a c c e p te d  and three theories have been 
postu la ted  to explain the physiological mechanisms of this phenom enon:
• the equa l pressure point theory [472]
• the Starling resistor theory [480], and
• the w ave  speed theory [475].
These theories are briefly discussed below .
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The equal pressure point theory
During inspiration, the intrapleural and alveolar pressures becom e increasingly negative as 
lung volume increases. This results in a corresponding increase in transmural pressure (i.e., 
the pressure ditterence between the inside and outside ot the airways), which contributes 
to the distention ot airway calibre. At end-inspiration, due to the mechanical inter­
dependence ot the airways and the lung parenchyma, high lung volume also maintains 
distention of airway calibre. During passive expiration, alveolar pressure (Paiv), which 
represents the sum of lung elastic recoil pressure (Pi) and pleural pressure (Ppi), provides 
the driving pressure for airflow along the airways downstream towards the mouth, where 
the pressure approximates atmospheric pressure. During forced expiration, the transmural 
pressure falls with decreasing lung volume and the airways becom e narrower. With 
increasing flow during a forced expiration, the driving pressure dissipates within the airways 
due to the need to overcome resistive forces. As expiration progresses, the intraluminal 
and extraluminal (or pleural) pressures becom e equal at certain sites along the 
intrathoracic airways, and such sites are known as the equal pressure points [472] (Figure 
1.9). Distal (mouthward) to the equal pressure point, the intraluminal pressure is less than 
that surrounding the airway walls externally. Consequently, airway compression occurs 
and flow becomes limited Figure 1.9.
Figure 1.9. A schematic diagram illustrating the concept of equal pressure point.
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At the site of the equal pressure point, intralum inal pressure = extralum inal pressure.
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The Starling resistor theory
This theory, derived from the principle of circulatory blood flow, proposes that the driving 
pressure for maximal expiratory flow is the difference between alveolar pressure and a 
critical transmural pressure. As air flows downstream (towards the mouth), the driving 
pressure within the airway dissipates such that at certain point, where the critical 
transmural pressure exceeds the driving pressure, the airway collapses sufficiently to limit 
flow [480]. Thus, the Starling resistor and the equal pressure point models share similar 
concepts in that during forced expiration, intrathoracic airways distal to certain points 
becom e narrowed subject to the transmural pressure, and that the principal driving force 
at maximal flow is the lung’s intrinsic elastic recoil [473:474].
The wave-speed theory
This theory postulates that the tracheobronchial tree, similar to other systems carrying 
flowing fluid, is unable to accom m odate an airflow faster than the speed at which 
pressures can propagate along the airways. The velocity at which pressures will propagate  
in a given system is referred to as the wave-speed [475]. The tendency for extraluminal 
pressure to compress the airway is opposed by the stiffness of the airway wall. As lung 
volume decreases during expiration, the airway calibre decreases and airway 
compliance increases, both of which reduce the maximal flow that can be carried by the 
airways. When extraluminal pressure exceeds intraluminal pressure downstream, a more 
compliant airway will tend to narrow resulting in a segment of the airway acting as a 
‘‘choke point” that limits flow.
During flow-limitation, the speed of gas molecules flowing in a tube or airway at the site of 
flow-limitation (choke point) equals the wave-speed and therefore bulk flow is the product 
of the wave-speed and the cross-sectional area at the choke point. The equation that 
predicts flow at wave-speed in the airway is:
Wave-speed flow = {1 /d )1/2- (dPtm /dA),/2• A3/2
where d is the gas density, Ptm is the transmural pressure, A is the airway cross-sectional 
area at the site of flow-limitation and dPtm/dA represent a measure of the airway wall 
elastance at the same site [481]. Thus, in airways with flexible or compliant walls, forced 
expiratory flow limited by this mechanism is inversely proportional to the gas density and  
directly proportional to airway wall elastance and cross-sectional area at the choke point. 
As such, the larger and stiffer the airway and the lower the gas density, the greater the 
flow that would be achieved through the airway.
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As forced expiration proceeds in healthy subjects, choke points multiply and cascade  
from central to peripheral airways. Flows measured at the mouth, however, reflect the 
integrated output of all the airways and therefore demonstrate only the stepwise 
movement of global sites of flow-limitation as these sites move from one level in the 
bronchial tree where flow has becom e limited in all contributing pathways to the next. A 
direct relationship cannot be m ade between flow measured at the mouth and the 
function of airways of any particular airway generation.
For the studies reported in this thesis, airway function was assessed using both partial and 
raised volume forced expiratory manoeuvres, by applying external thoraco-abdominal 
pressure at the end of a normal tidal inspiration, and after inflating the lungs to a pre­
determined positive pressure of approximately 3 kPa, respectively.
1.9. THE TIDAL RAPID THORACO-ABDOMINAL COMPRESSION (RTC) 
TECHNIQUE
1.9.1. Background
Although measurements using spirometry rapidly becam e established as the gold 
standard for assessing airway function in older children and adults in both clinical and  
research studies, such measurements were not possible in infants until the late 1970s. 
Despite the fact that infants cannot be asked to take a deep breath and breathe out 
forcibly, such manoeuvres can nevertheless be achieved by applying an external 
compressive force around the thorax and abdomen, while measuring flows at airway 
opening.
In 1977, Taussig e t  a l reported measurements of partial forced expiratory flows in 4-6 year 
old children [482]. In the same year, Motoyama et  al obtained full MEFV curves in 
intubated infants by applying a negative pressure at the airway opening after several 
passive lung inflations [483]. The following year, Adler and Wohl first described the 
application of an external rapid thoraco-abdominal pressure compression (RTC] during 
spontaneous tidal breathing in healthy, sedated infants placed within a negative pressure 
chamber, and succeeded in recording partial forced expiratory flow-volume (PEFV) 
curves using a pneum otachom eter (PNT) connected to a face mask placed over the 
nose and mouth [484], The externally applied compression pressure substituted voluntary 
effort to force expiration. Although effective, this technique was relatively cumbersome 
and was modified in the 1980s by substituting the pressure chamber with an expandable  
jacket, which was w rapped around the chest and abdomen and inflated at the end of a 
tidal inspiration to force expiration [485]. Commonly known as the ‘squeeze’ technique,
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the tidal RTC technique was the tirst practical, non-invasive method that was feasible for 
use in both healthy infants and those with lung disease.
Similar to spirometric measurements in older subjects, the tidal RTC technique aims to 
assess airway function by achieving expiratory flow-limitation. Since this assessment is 
performed over the tidal volume range, it is considered to be a measure of partial forced 
expiratory flow only. The maximal expiratory flow af FRC ( V ' m a x F R c ) ,  the principal param eter 
determined from PEFV curves, is thought to reflect the function of peripheral airways 
[ 109; 172:443:485]. Subject to flow-limitation, V'maxFRc is independent of effort and upper 
airway resistance [172], whereas peak forced expiratory flow is not considered to be 
useful, as it is mainly determined by compression pressure [486]. Due to its relative 
simplicity, the tidal RTC technique has since becom e one of the most extensively used 
techniques in physiological, pharmaceutical and clinical studies involving infants (Table 1.7 
to to Table 1.10). The body of information derived from these studies has contributed 
substantially to the knowledge of airway function in infancy.
1.9.2. Shape of PEFV curves
Previous studies using the tidal RTC technique reported marked within and between  
subject variabilities of V ’maxFRc [109:487], It has, therefore, been suggested that the 
sensitivity of PEFV curves can be increased by assessing the shape of the curves rather 
than reporting V'maxFRc values alone [488].
Having assessed the shape of the forced expiratory flow-volume portion as a reflection of 
airway status, Le Souef e t  a l [488] reported that convex (to the volume axis) curves are 
more common in normal infants, whereas concave curves are more frequently observed 
in infants with airway disease (Figure 1.10). In addition, infants with flow-limitation during 
tidal expiration, where application of external compression pressure does not increase 
expiratory flow, are likely to have more severe airway disease than those without flow- 
limitation on tidal expiration. Furthermore, these authors found that shape of the expiratory 
curve was determined by the external compression pressure and suggested that 
comparisons should be m ade at a standardised jacket transmission pressure whether or 
not flow-limitation had been reached [486:488]. As discussed later (section 1.9.3), this 
suggestion has, however, subsequently been challenged [489].
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Figure 1.10. PEFV curves obtained from a healthy infant and one with airway disease.
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(A): a convex flow-volum e curve from a hea lthy infant and (B): flow-volume curve from an 
infant of similar a ge  and  w e igh t w ith ev idence  of a irway obstruction, who not only had a 
m uch lower V '-  reco rded  but the trace  has a characteristica lly co nca ve  shape.
1.9.3. Jacket compression pressure
During forced expiratory manoeuvres, the driving pressure (indicated by the percentage  
of pressure transmitted across the chest wall from the expandable jacket to the pleural 
space and hence the intrathoracic structures) varies between infants. It is influenced by 
the type of jacket used and how tightly it has been applied, the amount of reservoir 
pressure delivered to the jacket bladder, and the intant's respiratory compliance  
[443:486],
To assist data  interpretation and quality control, it is essential to assess the transmission of 
jacket compression pressure. This can be measured using oesophageal manometry [490] 
or the airway occlusion technique to determine pressure throughout the respiratory system 
during an end-inspiratory airway occlusion prior to, and whilst jacket has been inflated 
[443:486], In the studies presented in this thesis (Chapters 3 and 4), the latter procedure 
was used to assess the magnitude of jacket compression pressure (P,) transmitted to the 
intrathoracic structures, i.e., the transpulmonary or driving pressure.
When an airway occlusion is performed during tidal breathing, under conditions of no air 
flow, pressure equilibrates within the lungs so that pressure at the airway opening (Pao) is 
equal to alveolar pressure (Paiv) (shown as PI in Figure 1.11). Provided the occlusion is
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